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ACUTE AND CHRONIC EFFECTS OF SULFAMETHOXAZOLE ON THE 
BIODEGRADATION OF ACETATE UNDER AEROBIC CONDITIONS AT 
LOW SLUDGE AGE 
SUMMARY 
The global distribution of pharmaceuticals in terrestrial or aquatic environment has 
become one of the main environmental problems in the last decade. Among all other 
pharmaceutical drugs and substances, antibiotics are one of the major groups of 
pharmaceuticals. Parallel to the increase in the extensive usage of antibiotics, it is 
unavoidable that these chemicals are released into the environment. Therefore, the 
adverse effect on the environment and health brought from the processing and disposal 
of these products become important issue in the field of environmental engineering.  
Very large numbers of antibiotics are used in human and veterinary medicine and also 
used to promote the growth of animals to improve the quality of the product. 
Antibiotics are industrially produced and commercially used, but they are not required 
to undergo the extensive level of testing for possible environmental impact. 
Antibiotics generally remain in the effluent of wastewater treatment plants due to 
difficult treatability with conventional treatment systems such as aerobic activated 
sludge system. The presence of these organic contaminants and their primary 
degradation products in the influents of wastewater treatment plants(WWTPs) may 
inhibit biological processes. For this reason, these substances are becoming an 
increasingly large problem in WWTPs, they also spoil ecological balance to form 
toxicity to organisms in ecosystem and biological treatment systems. 
In this context, the objective of this study was to investigate acute and chronic 
inhibition effects of antibiotic substances on the biodegradation of carbon source. 
Thus, the sulfamethoxazole was chosen as model antibiotic due to abundantly used 
antibiotic compound in the world and in Turkey. The sulfamethoxazole represents 
sulfonamide group of antibiotics and it blocks bacterial cell metabolism by inhibiting 
enzymes. 
Acetate used as a readily biodegradable carbon source in this study. The system 
operated at steady state conditions as namely “control reactor”. In other words, the 
inhibitory impact of sulfamethoxazole on the biodegradation of acetate by an 
acclimated microbial culture was investigated under aerobic conditions at a sludge age 
of 2 d. Substrate was added once a day by pulse feeding and biomass was acclimated 
to pulse feeding pattern in the aerobic batch reactor.  
After steady state conditions were established in the system, the acclimated biomass 
culture was taken to perform respirometric tests. Acetate was added on the biomass to 
have the same S0/X0 ratio with the control reactor and oxygen uptake rate was 
monitored for the assessment of substrate biodegradation behaviour.  
Additional respirometric experiments were conducted on the activated sludge to 
determine acute and chronic inhibition effects of antibiotics. The antibiotic was 
 xx 
givento system with different pulse feedings of 25 mg/L, 50 mg/L, 100 mg/L and 200 
mg/L of SMX concentrations to evaluate the acute effects on the carbon removal 
performance, however the chronic experiments were done with continuous feeding of 
50 mg/L of SMX concentration.  
Moreover, it is also aimed to determine the responses of the activated sludge culture to 
antibiotic substances by means of modeling tools which enables to determine the 
kinetic and stoichiometric constants of the mixed culture. Therefore, relevant kinetic 
and stoichiometric coefficients were achieved using modified ASM3 pattern in the 
study.According to model simulations results of acute experiments, maximum specific 
growth rate (µHmax) decreased whereas the half saturation coefficient (KS) increased 
with the addition of high concentration of SMX to the system. In addition, the 
maximum specific growth rate for storage (μSTO) also decreased in these system. On 
the other hand, model simulations results of chronic experiments indicated that, only a 
portion of acetate was utilized by the microorganisms in the growth process. The other 
portion of acetate made a complex with antibiotic that was consumed as readily 
hydrolysable COD fraction in the hydrolysis process. Approximately 40 mg COD/L 
antibiotic was removed throughout the chronic experiments with a specific hydrolysis 
rate.  
As a consequence, all acute and chronic results under aerobic conditions at a sludge 
age of 2 d demonstrated that the metabolism of the activated sludge was shifting from 
storage to growth. The biomass prefers to direct growth process rather than storage 
process. 
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 SÜLFAMETOKSAZOL’ÜN AEROBİK ORTAMDA DÜŞÜK ÇAMUR 
YAŞINDA ASETATIN BİYOLOJİK AYRIŞABİLİRLİĞİ ÜZERİNE AKUT VE 
KRONİK ETKİLERİ 
ÖZET 
İlaçların yeryüzünde genel dağılımı, son on yıllık süre içinde en önemli çevre 
problemlerinden biri olarak karşımıza çıkmaktadır. Tıbbi ilaç, insanlarda ve 
hayvanlarda hastalıklardan korunma, tanı, tedavi veya bir fonksiyonun düzeltilmesi ya 
da insan (hayvan) yararına değiştirilmesi için kullanılan, genelde bir veya daha fazla 
yardımcı maddeler ile formüle edilmiş etkin madde(ler) içeren bitmiş dozaj şekli 
olarak tanımlanabilir. Son yıllarda yapılan çalışmalarda sucul ve diğer ortamlarda 
(çevresel ortam) tıbbi ilaçlardan kaynaklanan mikrokirleticilerin görülmesi ve bunların 
bu ortamlarda yaşayan canlılara olan olumsuz etkilerinin ortaya konması, endişeleri 
arttırmıştır. Yapılan çalışmalarda; cinsiyet oranlarının değişmesi, cinsiyet tersinimleri, 
popülasyonların azalması, yumurtlama ve canlı kalma oranlarının azalması gibi 
sonuçlar organizmalar üzerinde ilaçlardan kaynaklanan ve tespit edilen bazı etkiler 
arasındadır. 
Günümüzde ilaçların kullanım sonucu çevresel ortamlardaki taşınımı, bozunumu, 
dönüşümü, miktarları ve nihai akıbetleri konularında sınırlı bilgi mevcuttur. Son on 
yıllık süre içinde mevcut ilaçların sucul ortamlarda tespit edilmeleri, bu ilaçların daha 
önceleri sucul ortamlarda bulunmadığı anlamına gelmemektedir.  Daha hassas ve daha 
düşük konsantrasyonları ölçülebilen yeni bilimsel metotların ve analitik ölçüm 
yöntemlerinin geliştirilmesi ile bu ilaçların oluşturabilecekleri olumsuz etkiler yavaş 
yavaş ortaya konmaya başlanmıştır. 
Gelişmiş ülkelerde tıbbi kimyasal için uluslararası düzeyde detaylı mevzuatlar mevcut 
değildir. Ancak ürkütücü olabilecek potansiyel etkilerinden dolayı gittikçe popüler 
hale gelen bu konuda özellikle gelişmiş ülkelerde toplum baskısı artmaktadır. 
Dolayısıyla, yakın gelecekte tıbbi kimyasal olmasından şüphe edilen birçok sentetik 
ilaç için, yeni ve çok sıkı mevzuatların getirilmesi ve buna bağlı olarak da atıksu 
arıtma tesisi deşarj standartlarının da çok daha sıkı olması beklenmektedir.  
Dünyada ve ülkemizde en çok tüketilen ilaç gruplarının başında antibiyotikler 
gelmektedir. Yunanca anti (karşı) ve bios (yaşam) sözcüklerinden türetilen antibiyotik 
sözcüğü; küf mantarlarında bulunan ya da yapay olarak üretilen, bakteri ve diğer 
mikroorganizmaların gelişimini durduran ya da onları yok eden maddelerin ortak adı 
olarak tanımlanmaktadır. 19. yüzyılın ortalarında Louis Pasteur bir 
mikroorganizmanın diğer bir mikroorganizmanın büyümesini engellediğini 
keşfetmiştir. Bu keşfi ise uygulama alanına ilk koyan kişi Sir Alexander Fleming 
olmuştur. 1928 yılında Fleming belirli bir küf (Penicillium notatum) tarafından enfekte 
olan kaplarda bakterilerin gelişmesinin durduğunu raslantı sonucu keşfederek, küf 
tarafından salınan bir madde ile bakterilerin öldüğü sonucunu çıkarmıştır. Üreyen küf 
mantarlarının Penisillinin türünden oluşundan esinlenerek, etkili maddeye ‘penisilin’ 
adını vermiştir. 1940 yılında penisilinin yüksek etkinliğinin deneysel olarak 
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kanıtlanmasından sonra, değişik gruplardan da birçok antibiyotik geliştirilmiştir. 
Bulaşıcı bakteri ve mantarlarla savaşmak için yararlanılan antibiyotikler 1940’dan bu 
yana kullanılmaktadır. Antibiyotikleri çeşitli kriterlere göre sınıflandırmak 
mümkündür. Antibiyotikler, mikroorganizmalar üzerindeki etki derecelerine, etki 
mekanizmalarına, kimyasal yapılarına ve farmakokinetik özelliklerine göre çeşitli 
şekillerde sınıflandırılabilir.  
Antibiyotiklerin birçoğu veterinerlik ve tıp alanında kullanılmakta, ayrıca ürün 
kalitesini geliştirmek için hayvanların büyümesinde besin olarak da verilmektedir. 
Avrupa birliği ülkelerinde insan ve veteriner ilaç yapımında yaklaşık 4.000 farklı 
etken madde  kullanılmaktadır. Antibiyotikler endüstriyel olarak üretilip, ticari olarak 
kullanılsa da, onların çevreye olan olası etkileri önemli bir ölçüde 
değerlendirilmemiştir.  
Gelişmiş ülkelerde ilaçların tüketim sıralamasında antibiyotikler 5. sırada yer alırken, 
ülkemizde (%16,3) birinci sırada bulunmaktadır. Ülkemizde 40 dolar olan yıllık kişi 
başına ilaç tüketiminin %21’ini antibiyotikler ve benzeri ilaçlar oluşturmaktadır. Bu da 
ülkemizde antibiyotiklerin genel ilaç giderleri arasındaki payının dünya 
standartlarından yaklaşık 2,5 kat fazla olduğunu göstermektedir. Bu fazla tüketime ek 
olarak antibiyotik uygulamalarının yaklaşık %50’sinin uygunsuz olduğu bilinmektedir. 
Türk Eczacılar Birliği’nin verilerine göre, son beş yılda yaklaşık 1,5 milyar kutuya 
yakın antibiyotik tüketilmiştir. Ayrıca bu verilere; yüzde 80’ni hayvanlara verilen ve 
dolayısıyla hayvanlardan insanlara geçen antibiyotikler ile doktorlara promosyon 
olarak verilen antibiyotikler dâhil değildir. Bu kimyasalların gereksiz ve fazla 
kullanımının artmasıyla, antibiyotikler kaçınılmaz bir şekilde çevreye yayılmaktadır. 
Bu nedenle, antibiyotiklerin işlenmesinin ve bertarafının çevreye ve sağlığa negatif 
etkileri çevre mühendisliği alanında önemli bir sorun haline gelmiştir.  
Hastahaneler, ilaç endüstrileri ve evler antibiyotiklerin başlıca kirletici kaynakları 
arasında yer almaktadır. Özellikle bilinçsiz kullanım sonucu giderek kullanımı artan 
antibiyotikler biyolojik ayrışmaya karşı dirençli olup, insan vücudu tarafından dışkı ve 
üre ile atılarak,  evsel nitelikli atıksu arıtma tesislerine taşınmaktadır. Dolayısıyla evsel 
nitelikli atıksu arıtma tesisleri ortama antibiyotik etken maddesi veren ciddi birer 
işletme haline gelmiştir. Şuanda mevcut olan atıksu arıtma tesisleri büyük oranda, 
tesise düzenli olarak gelen organik maddelerin (öncelikle karbon, azot, fosfor gibi 
nütrientlerin) giderimi üzerine projelendirilmiştir. Aerobik aktif çamur sistemi gibi 
geleneksel arıtma sistemleri bu tür maddeleri gidermek için tasarlanmadığından çeşitli 
sorunlar da beraberinde gelmektedir. Atıksu arıtma tesislerinde antibiyotiklerin farklı 
kimyasal yapılarından dolayı farklı oranlarda arıtıldığı veya hiç arıtılamadığı 
bilinmektedir. Ayrıca bu organik kimyasalların ve onların birincil yıkım ürünlerinin 
atıksu arıtma tesislerinin giriş sularında bulunması biyolojik prosesler açısından 
inhibisyon etkisi oluşturabilir. Bu nedenle bu maddeler atıksu arıtma tesislerinde 
büyük bir sorun haline gelmiştir. 
Atıksu arıtma tesislerinde bulunan antibiyotiklerin giderim oranları üzerindeki 
çalışmalar çoğunlukla giriş ve çıkış atıksuyu konsantrasyonlarının ölçülmesi esasına 
dayanmaktadır. Giderim oranları; kullanılan arıtma teknolojisine, hidrolik bekletme 
süresine, mevsimsel koşullara ve arıtma tesisinin performansına bağlı olarak büyük 
değişiklikler göstermektedir. Bu nedenle antibiyotikler ekosistemde ve biyolojik 
arıtma sistemlerinde organizmalar için toksisite etki oluşturarak ekolojik dengeyi de 
bozmaktadır. Kısmen veya hiç arıtılamadan alıcı ortama verilen antibiyotikler 
nehirlerin, göllerin, denizlerin ve sıklıkla da yeraltı ve içmesularının kirlenmesine 
neden olmaktadır. Gelişen bilimsel metotlar ve analitik ölçüm yöntemleriyle birlikte; 
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daha önceden tespit edilemeyen birçok mikrokirletici tespit edilmeye başlanmıştır. 
Bununla birlikte mevcut analitik yöntemlerle tespit edilemeyen birçok kirleticinin 
olduğu ve mevzuatlarla da sınırlandırılamadığı için düşük konsantrasyonlarda alıcı 
ortamlara doğrudan deşarj edildiği düşünülmektedir.  
Antibiyotiklerin diğer bir kirletici kaynağı ise; veteriner ilaçlarının kullanımı sonucu 
oluşan gübrelerin tarımda kullanılması ile meydana gelmektedir. Tarımda kullanılan 
veya araziye serilen bu gübreler ve arıtma çamurları toprağa sızarak yeraltı sularına, 
nihai olarak da içme sularına ulaşmakta ve kirliliğe neden olmaktadır. Bu maddeler 
mikrobiyal ekolojiyi etkileyerek, antibiyotiklere dayanıklı patojenlerin üremesinin 
artmasına neden olmakta ve böylelikle başta insanlar olmak üzere hayvanlar ve bitkiler 
üzerinde olumsuz etkiler yaratmaktadır. Günümüze kadar çeşitli Avrupa ülkelerinde 
yapılan çalışmalarda arıtma tesisi çıkış sularında, yüzeysel ve yeraltı sularında 100’ün 
üzerinde ilaç bileşimine rastlandığı bildirilmiştir. Bu tip alıcı ortamdaki canlılara 
toksik etki yapabilecek bileşiklerin potansiyel toksik etkileri üzerine pek fazla çalışma 
yapılmamış olduğu da dikkat çekicidir. Yapılan araştırmalarda sistemde ya sadece 
kollektif parametrelerin ölçüldüğü ya da sadece antibiyotik konsantrasyonlarının 
izlendiği görülmektedir. 
Antibiyotiklerin çevresel ortamda canlılar üzerindeki etkileri akut ve kronik etkiler 
olmak üzere iki farklı alanda değerlendirilebilir. Akut etki, antibiyotiklerin tek bir doz 
uygulaması sonucunda ve genellikle kısa bir süre içerisinde meydana getirdiği zarar 
olarak ifade edilir. Kronik etki ise, uzun süre boyunca canlıların bu kimyasal 
maddelere maruz bırakılması ile belirlenir. Zamanın belirli periyodlarında tekrar tekrar 
kullanılan küçük dozlardan ortaya çıkan her türlü zarar kronik etki olarak ifade edilir. 
Bazı antibiyotiklerin akut toksisite etkileri hakkında yapılan çalışmalarda çeşitli tedavi 
gruplarından farklı ilaçların toksisite verileri elde edilmiştir. Yapılan akut toksisite 
deneylerinde, sucul organizmalara akut etki yapan konsantrasyonların, ilaç 
kalıntılarından dolayı çevresel ortamlarda bulunan konsantrasyonlardan 100-1.000 kat 
daha yüksek olduğu görülmüştür. Bu nedenle ilaçların doğrudan sucul ortamlara 
dökülmesi durumunda, sucul canlılara akut toksisite tehditi oluşturacağı ifade 
edilmektedir. Bunun yanı sıra, birçok sucul ortamda yaşayan canlı türleri uzun süreli 
veya tüm yaşamı boyunca antibiyotik gibi mikrokirleticilerin etkisinde kalmış da 
olabilir. Bu nedenle bu mikrokirleticilerin kronik potansiyel etkilerinin 
değerlendirilmesi önem arz etmektedir. Ancak antibiyotiklerin kronik etkileri hakkında 
çok az veri bulunmakta olup, bunların kronik toksisite etkileri genellikle 
bilinmemektedir. Bu konuda çok daha fazla spesifik çalışmaların yapılması 
gerekmektedir.  
Bu çerçevede, bu çalışmanın amacı; aktif çamur sistemlerinde antibiyotik 
mekanizmasının ortadan kaldırılmasının ve bu kimyasalların karbon kaynağı 
biyodegradasyonu üzerindeki akut ve kronik inhibisyon etkilerinin  araştırılmasıdır. 
Bu nedenle, dünyada ve Türkiye’de yaygın olarak kullanılan sülfametoksazol model 
antibiyotik olarak seçilmiştir. Antibiyotik sınıflandırılmasında sülfonamid grubunu 
temsil eden sülfametoksazol, bakterinin bünyesinde olan enzimleri inhibe ederek 
metabolizmalarını bloke eder. Literatürde yapılan çalışmalarda sülfametoksazolün 
giderimi ile ilgili olarak kesin bir bilgi bulunmamaktadır. 
Substrat aerobik kesikli reaktörde ani besleme ile günde bir defa sisteme eklenmiş ve 
biyokütle ani beslemeye aklime edilmiştir. Sülfametoksazolün, karbon kaynağına 
aklime olan bir aerobik mikrobiyal kültürde subsrat ayrışması üzerine olan etkilerinin 
araştırılması hedeflenmiştir. Bu kapsamda, asetat biyolojik olarak kolay ayrışabilir bir 
karbon kaynağı olarak kullanılmıştır. Çalışmanın başında iki çamur yaşında bir adet 
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doldur-boşalt tipi reaktör kurulmuş ve reaktör asetat karışımı ile beslenerek kararlı 
denge haline ulaştırılmıştır. Kontrol reaktörü adı verilen biyokütle kaynağı tüm 
deneysel çalışma boyunca çalıştırılmıştır. Daha sonra, sülfametoksazolün aerobik 
ortamda iki gün çamur yaşında asetatın biyolojik ayrışabilirliği üzerine akut ve kronik 
inhibisyon etkileri araştırılmıştır.  
Sistemde kararlı denge koşulları sağlandıktan sonra, aklime olan biyokütle 
respirometrik deneyleri gerçekleştirmek için reaktörden alınmıştır. Asetat ve biyokütle 
karışımı, kontrol reaktörüyle aynı besin ve biyokütle oranıyla respirometreye 
eklenmiştir. Oksijen tüketim hızı, substrat biyodegradasyonu değerlendirmek amacıyla 
deney boyunca takip edilmiştir.  
Respirometre deneyleriyle ayrıca antibiyotiğin aktif çamur sistemine akut ve kronik 
etkileri değerlendirilmiştir. Antibiyotiğin karbon giderimi üzerindeki akut inhibisyon 
etkilerini araştırmak için respirometreye 25 mg/L, 50 mg/L, 100 mg/L ve 200 mg/L’lik 
dört farklı antibiyotik konsantrasyonu anlık besleme olarak eklenmiştir. Akut 
inhibisyon etkileri 5 set deneysel çalışma ile gerçekleştirilmiştir. 
Ayrıca aktif çamur sisteminin antibiyotiklere kronik maruz kalmalarının etkilerinin 
incelenmesi amacıyla, bir adet daha doldur-boşalt tipi reaktör işletilmiş ve farklı 
günlerde yapılan deneylerle toplam 10 set deneysel çalışma gerçekleştirilmiştir. 
Kurulan kronik reaktör 50 mg/L’lik sülfametoksazol konsantrasyonu ile sürekli olarak 
beslenmiştir. Deneysel çalışmalarda ise karışık substrat (antibiyotik ile asetat), yalnız 
asetat ve yalnız antibiyotik olmak üzere üç farklı karbon kaynağı uygulanmıştır.  
Akut ve kronik çalışmalardaki substrat tüketimi, respirometre deneyleriyle ulaşılan 
oksijen tüketim profillerinin gözlemlenmesi ile incelenmiş ve antibiyotik etkisi altında 
olmayan kontrol reaktörünün oksijen tüketim profili ile model simülasyonlarından 
yararlanılarak karşılaştırılmıştır. Model simülasyon sonuçları ile gerekli kinetik ve 
stokiyometrik katsayılar modifiye edilmiş ASM3 modeli kullanılarak belirlenmiştir. 
Akut inhibisyon deneylerinin sonuçları karşılaştırıldığında, antibiyotik 
konsantrasyonunun arttırılmasıyla; maksimum heterotrofik çoğalma hızı (µHmax) 
azalırken, heterotrofik yarı doygunluk sabiti (KS) artmaktadır. Ayrıca, maksimum 
depolama hızı (μSTO) da deneyler sırasında azalmıştır. Diğer taraftan kronik inhibisyon 
deneylerinin sonuçları değerlendirildiğinde, asetatın belli bir kısmı çoğalma 
prosesinde tüketilmiş, kalan kısmı ise antibiyotik ile kompleks oluşturarak hızlı 
hidroliz olabilen yavaş ayrışabilir çözünmüş KOİ olarak tüketilmiştir. Tüm kronik 
deney boyunca yaklaşık olarak 40 mg KOİ/L antibiyotik belirli bir hidroliz hızıyla 
giderilmiştir. Tüm akut ve kronik inhibisyon sonuçları değerlendirildiğinde; aktif 
çamur metabolizmasının depolama prosesinden çoğalma prosesine doğru kaydığı 
saptanmıştır.  
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1.  INTRODUCTION 
Life on this planet is based on the continuous cycling of elements. In recent years the 
massive mobilization of natural resources and the industrial synthesis of chemicals 
have generated a number of environmental problems as a consequence of the limited 
incorporation of natural and synthesized molecules into ongoing biological cycles. 
This is particularly true for pharmaceutical compounds, which are accumulated or 
induce adverse effects in terrestrial or aquatic organisms (Kümmerer, 2009a). 
The global distribution of pharmaceuticals in the aquatic environment has become 
one of the main environmental problems in the last decade (Zuccato et al, 2005). 
Among all pharmaceutical drugs and substances, antibiotics are one of the major 
groups of pharmaceuticals due to its serious irreversible increase in the release to the 
environment. Very large numbers of antibiotics used in human and veterinary 
medicine are industrially produced and commercially used, but they are not required 
to undergo the extensive level of testing for possible environmental impact (Gotvajn 
et al, 2007).Antibiotics are also used to promote the growth of animals where they 
are used at low doses in animal feeds and are considered to improve the quality of 
the product.  
Antibiotics generally remain in the effluent of wastewater treatment plants due to 
difficult treatability with conventional treatment systems such as aerobic active 
sludge systems. For that reason, they spoil ecological balance to form toxicity to 
organisms in ecosystem and biological treatment systems.The biodegradability and 
adverse effects of antibiotic compounds in engineered systems was investigated in a 
number of studies which focused on their adverse effects on treatment systems. 
Recent works have reported the presence of a large variety of antibiotics in WWTP 
effluents and surface waters, with concentrations up to several μg/L. According to 
literature, antibiotic concentrations in pharmaceutical wastewaters are reported to 
increase up to 200 mg/L (Ozkok et al, 2011; Drillia et al, 2005). In order to 
investigate the elimination mechanism of antibiotic substances in activated sludge 
systems and their effects on these systems, a model substance was chosen in this 
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study. The sulfamethoxazole was chosen as model antibiotic to represent 
sulfonamide group of antibiotics. This substance, which is among the abundantly 
used antibiotic compounds in the world and in Turkey (Kümmerer and Henninger, 
2003). 
1.1 Aim of the Thesis 
The aim of this study is to investigate acute and chronic effects of sulfamethoxazole 
on the biodegradation of acetate under aerobic conditions at low sludge agein the 
activated sludge system. After steady state conditions were established in the system, 
activated sludge culture was taken to perform respirometric tests for acetate removal 
mechanisms and acute and chronic effects of antibiotic substance. In literature, the 
majority of the studies examined effects of lower concentrations of antibiotics 
characterizing wastewater generated after usage of these compounds. However, 
control of antibiotics at source, in the effluent of the pharmaceutical industry is 
equally important. Therefore, in this study, higher antibiotic concentrations were 
chosen in order to represent antibiotic production wastewaters. 
Finally, the biochemical processes occurring under inhibiting and non-inhibiting 
conditions were modelled with the aid of the results obtained from experimental 
studies. It is also aimed to determine the responses of the activated sludge culture to 
antibiotic substances by means of modelling tools which enables to determine the 
kinetic and stoichiometric constants of the mixed culture. 
1.2 Scope of the Thesis 
This study was started up with the set up a laboratory-scale fill and draw reactor, 
namely “control reactor”. The control reactor was operated at a sludge age of 2 days 
with the initial carbon source concentration of approximately 400 mg COD/L. 
Acetate representing readily biodegradable substrate was chosen as sole carbon 
source. The reactor was inoculated with activated sludge taken from the acetate 
acclimated biomass used in another study. Substrate was added once a day by pulse 
feeding and biomass was acclimated to pulse feeding pattern in the aerobic batch 
reactor. Reactor was operated until it reached steady state conditions, which was 
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monitored by conventional parameter analysis such as suspended solids, volatile 
suspended solids and chemical oxygen demand measurements. 
After the control reactor reached at steady state conditions; the acclimated biomass 
was used for respirometric experiments. Acetate mixture was added on the biomass 
to have the same S0/X0 ratio with the control reactor and oxygen uptake rate was 
monitored for the assessment of substrate biodegradation behaviour. Additional 
respirometric experiments were conducted on the activated sludge to determine acute 
and chronic inhibition effects of antibiotics. The antibiotic was given to system with 
different pulse feedings of 25 mg/L, 50 mg/L, 100 mg/L and 200 mg/L of SMX 
concentrations to evaluate the acute effects on the carbon removal performance, 
however the chronic experiments were done with continuous feeding of 50 mg/L of 
SMX concentration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 4 
 
 
 
 
 
 
 
 
 
 
 
 5 
2.  LITERATURE REVIEW 
2.1 Pharmaceutical Industry 
Xenobiotics are chemicals which are not generated by living organisms and alien to 
natural systems such as poisons, drugs, and environmental pollutants. The evaluation 
of the metabolism processes of xenobiotics gain interest in recent years. Metabolism 
of the xenobiotics, which refers the various metabolic pathways depending on the 
structure of the chemicals, is important for life, as it allows an organism to neutralize 
and eliminate foreign toxins that would otherwise interfere with the chemical 
processes that keep it alive. These chemicals are continuously produced in greater 
numbers, mostly as raw materials or auxiliaries for industrial activities and they end 
up in waste streams. By their nature, they are mostly resistant to biodegradation 
(Orhon et al, 2010). 
As xenobiotics are not normally found in an organism as part of its natural 
biochemistry, they are not easily incorporated into biogenic element cycles and 
consequently they are permanently or transitory accumulated in the environment. 
These chemicals have multiple applications in the synthesis of polyurethane foams, 
herbicides, insecticides, pharmaceuticals, and explosives, all of which are more 
recalcitrant than the raw material from which they are synthesized (Ramos et al, 
2001). 
The products of xenobiotics that are indispensable part of our daily life help to 
pursue the modern way of living and contribute to our high standards in living and 
safety, mobility, communication technologies, food, health, textiles and drinking 
water treatment, among many others. These products are generally labelled under the 
categories such as: pharmaceuticals, medicines, disinfectants, pesticides, detergents, 
fertilizers, dyes, paints, food additives and personal care products (Kümmerer, 
2009a). 
Pharmaceutical substances often have similar physico-chemical behaviour as other 
harmful xenobiotics that are accumulated or induce adverse effects in terrestrial or 
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aquatic organisms. Pharmaceuticals (antibiotics, antidepressants, and may other 
chemicals) are examples of such xenobiotics which have the potential to accumulate 
in the food chain and threaten human health (van der Meer et al, 1992). The global 
distribution of pharmaceuticals in the aquatic environment has become one of the 
main environmental problems in the last decade (Zuccato et al, 2005). Very large 
numbers of substances used in human and veterinary medicine are industrially 
produced and commercially used, but they are not required to undergo the extensive 
level of testing for possible environmental impact (Gotvajn et al, 2007). 
Parallel to the increase in the extensive usage of pharmaceuticals, it is unavoidable 
that these chemicals are released into the environment. Therefore, the adverse effect 
on the environment and health brought from the processing and disposal of these 
products become important issue in the field of environmental engineering (Hirsch et 
al, 1999). Because of its continuous introduction in the environment, are considered 
as “pseudo persistent compounds” in the environment. Pharmaceutical residues 
and/or their metabolites that have been detected in different environmental 
compartments including antibiotics, analgesic and anti-inflammatory, lipids regulator 
agents, antiepileptics, contraceptives, steroids and related hormones. Although, the 
environmental concentrations of pharmaceuticals are generally at trace levels (ng/L 
to low µg/L) in the environment, can be sufficient to induce toxic effects (Hernando 
et al, 2006). 
The literature is sparsely documented with reported cases of pharmaceuticals from 
the early 1950s; however it wasn't until the mid 1990s that focused research into the 
fate and consequences of such compounds commenced (Hirsch et al, 1999). At the 
end of the last century, it was realised that the products of chemical and 
pharmaceutical industries are presenting a new type of environmental pollution that 
may also pose a health risk to the consumer. Pharmaceuticals and their metabolites 
have been subject to many years of unrestricted emission to the environment, directly 
or via sewage treatment plant effluents or sludge. Persistence toward biological 
degradation and their biological activity are key properties of these pollutants, since 
they have been designed to cause DNA damage to bacteria or eukaryotic cells. They 
retain their chemical structure long enough to do their therapeutic work and because 
of their continuous input they could remain in the environment for a long time 
(Alexy et al, 2004). The topic of  pharmaceuticals and personal care products 
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(PPCPs) as pollutants is intimately tied to a bewildering array of phenomena that 
transport and transform these chemicals from one place to another via a multitude of 
distinct “routes” by which the chemical is emitted, dispersed, or otherwise introduced 
to the next “compartment” or ultimately to a biological receptor. The fate and 
transport complexity of PPCPs can be seen in Figure 2.1. (Petrović and Barceló, 
2007). 
Reduction of pharmaceutical compounds in municipal sewage, through conventional 
biological treatment systems is a significant but insufficient means in mitigating their 
potential environmental impact. Pharmaceutical compounds in discharges derived 
from hospitals and pharmaceutical manufacturing sites can further increase the risk 
placed on the environment by municipal wastewater treatment plant (WWTP) 
effluents. Aga et al. (2005) stated that many of the pharmaceutical pollutants are 
resistant to biodegradation in WWTPs are also eliminated in the effluent by sorption 
on sludge.  
Typical pharmaceutical wastewater has the COD, sulphate and total suspended solids 
(TSS) concentrations of 12500 mg/L, 9000 mg/L and 36000 mg/L, respectively. 
Moreover the antibiotic concentrations in the pharmaceutical wastewaters have been 
reported to increase until 200 mg/L (Drilla et al, 2005; Kim et al, 2005). Coagulation, 
chemical precipitation and biological treatment by activated sludge systems can be 
given among the classical treatment methods of pharmaceutical wastewaters. 
Elimination of pharmaceuticals in wastewater treatment plants is depended on many 
parameters like the sludge age, hydraulic retention time, temperature, pH, biomass 
concentration, polarity and biodegradability of the substance (Press and Kristensen, 
2007). 
Wastewater treatment plants (WWTPs) are usual receptors of pharmaceuticals in 
which these compounds co-treated with municipal wastewaters before being 
discharged to the environment. The presence of these organic contaminants and their 
primary degradation products in the influents of WWTPs may inhibit biological 
processes (Kornaros et al, 2006).Therefore, these substances are becoming an 
increasingly large problem in WWTPs, since they are relatively new substances and 
are very difficult to categorize. 
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5.Direct release to open waters via washing/bathing/swimming  
6.Discharge of regulated/controlled industrial manufacturing waste 
streams  
7.Disposal to landfills via domestic refuse, Leaching from landfills, 
medical wastes, and other hazardous wastes 
8.Release to open waters from aquaculture (medicated feed and resulting 
excreta)  
Future potential for release from molecular pharming (production of 
therapeutics in crops)  
9.Release of drugs that serve double duty as pest control agents:  
10.Ultimate environmental transport/fate 
 
LEGEND 
1.Usage by individuals (1a) and pets (1b):  
Disposal of euthanized/medicated animal carcasses serving as food for scavengers (1c)  
2.Release of treated/untreated hospital wastes to domestic sewage systems ;  
also disposal by pharmacies, physicians, humanitarian drug surplus  
3.Release to private septic/leach fields (3a)  
Treated effluent from domestic sewage treatment plants discharged to surface waters (3b)  
Overflow of untreated sewage from storm events and system failures directly to surface waters 
(3b)  
4.Transfer of sewage solids ("biosolids") to land (e.g., soil amendment/fertilization)  
Release from agriculture: spray drift from tree crops (e.g., antibiotics) 
Figure 2.1 : Origins and fate of PPCPs in the environment (Url-1, 2012). 
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In addition, some of them are not completely degraded in WWTPs and remain in the 
water effluent. Others may be release in a modified form, either hydrolysed or 
conjugated (e.g. ibuprofen is removed in more than 90%, and transformed in 
hydroxyl and carboxy transformation products) (Hernando et al, 2006). For instance, 
antibiotics are excreted as the parent compound, in conjugated form, or as oxidation 
or hydrolysis products (Plosz et al, 2010). 
Most of pharmaceuticals were still detected in biologically treated gray water 
(kitchen sinks, laundry, hand basins, showers, and baths) in the low μg/L range. Until 
now, gray water treatment technologies focused on parameters such as chemical and 
biochemical oxygen demand (COD and BOD, respectively), nutrients, and 
pathogens. Eriksson et al. (2003) identified most ofpharmaceuticalsin gray water, and 
this may have a negative impact on the environment if they persist in recycled water 
or if discharged to water bodies. 
2.2 Antibiotics 
Antibiotics are one of the major groups of pharmaceuticals. Among all the other 
pharmaceutical drugs and substances, antibiotics are important compounds due to its 
serious irreversible increase in the release to the environment. Antibiotics are 
generally remain in the effluent of treatment plants and reach to receiver media due 
to difficult treatability with conventional treatment systems such as aerobic active 
sludge system and also their hydrophilic property. For that reason, they spoil 
ecological balance to form toxicity to organisms in ecosystem and biological 
treatment systems (Demirden, 2005). The word "antibiotics" comes from the Greek 
anti ("against") and bios ("life"). An antibiotic is a drug that kills or slows the growth 
of bacteria. Antibiotics are one class of antimicrobials, a larger group which also 
includes anti-viral, anti-fungal, and anti-parasitic drugs. The classical definition of an 
antibiotic is a compound produced by a microorganism which inhibits the growth of 
another microorganism (Beers et al, 2003). 
The first antibiotic was discovered by Alexander Fleming in 1928 in a significant 
breakthrough for medical science. Over the last 50 years, antibiotics have 
transformed the patterns of disease and death. Each different type of antibiotic affects 
different bacteria in different ways. Some antibiotics can be used to treat a wide 
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range of infections and are known as 'broad-spectrum' antibiotics. Others are only 
effective against a few types of bacteria and are called 'narrow-spectrum' antibiotics. 
Over the years, this definition has been expanded to include synthetic and semi-
synthetic products (Kümmerer, 2009a). 
Antibiotics are suspicious environmental contaminants as they are biologically 
active, which obviously is a part of their nature. Antibacterial agents are usually very 
soluble. In order to be as effective as possible, they often have a low 
biodegradability. This property poses a potential for bioaccumulation and persistence 
in the environment. Drugs, which have specific mode of actions, may probably exert 
effects on terrestrial and aquatic ecosystems, when released into the environment 
(Wollenbergera et al, 2000). 
An antibiotic in a broader sense is a chemotherapeutic agent that inhibits or abolishes 
the growth of microorganisms, such as bacteria, fungi, or protozoa because 
antibiotics are designed to affect microorganisms. Although, the term antibiotic 
originally referred to any agent with biological activity against living organisms,  
‘‘antibiotic” now refers to substances with their antibacterial, anti-fungal, or anti-
parasitical activity. There are currently about 250 different chemical entities 
registered for use in human and veterinary medicine (Kümmerer and Henninger, 
2003). Currently, antibiotics are obtained by chemical synthesis, such as the sulpha 
drugs (e.g. sulfamethoxazole), or by chemical modification in natural origin of 
compounds. Many antibiotics are relatively small molecules with a molecular weight 
of less than 1000 Da (Kümmerer, 2009a). 
2.2.1 Classification of antibiotics 
Antibiotics can be grouped by either their chemical structure or mechanism of action. 
The most common method classifies them according to their chemical structure as 
antibiotics sharing the same or similar chemical structure will generally show similar 
patterns of antibacterial activity, effectiveness, toxicity and allergic potential (Ternes 
and Joss, 2007; Beers et al, 2003). 
The main classes of antibiotics are:  
 Beta-Lactams  
 Macrolides 
 Fluoroquinolones 
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 Sulphonamides 
 Tetracyclines 
 Aminoglycosides 
Most commonly used types of antibiotics are Aminoglycosides, Penicillins, 
Fluoroquinolones, Cephalosporins, Macrolides, and Tetracyclines. They are often 
complex molecules, which may possess different functionalities within the same 
molecule. Therefore, under different pH conditions, antibiotics can be neutral, 
cationic, anionic, or zwitterionic. Because of the different functionalities within a 
single molecule, their physico-chemical and biological properties (Cunningham, 
2008), sorption behaviour, photo reactivity and antibiotic activity and toxicity may 
change with pH (Kümmerer, 2009a). 
2.2.1.1 Beta-Lactams 
Penicillins were the first and oldest class of antibiotics produced by fungi in the 
genus Penicillium, or streptomycin from bacteria of the genus Streptomyces. 
Penicillins are generally bactericidal, inhibiting formation of the cell wall (Url-5 and 
Url-6, 2012). 
2.2.1.2 Macrolides 
The macrolide antibiotics are derived from Streptomyces bacteria, and got their name 
because they all have a macro cyclic lactones chemical structure. The macrolides are 
bacteriostatic, binding with bacterial ribosomes to inhibit protein synthesis. 
Erythromycin, the prototype of this class, has a spectrum and is used similar to 
penicillin (Url-5 and Url-6, 2012). 
2.2.1.3 Fluroquinolones 
Fluoroquinolones (fluoridated quinolones) are the newest class of antibiotics. Their 
generic name often contains the root "floxacin". They are synthetic antibiotics, and 
not derived from bacteria. Fluoroquinolones belong to the family of antibiotics called 
quinolones.Fluoroquinolones inhibit bacteria by interfering with their ability to make 
DNA. This activity makes it difficult for bacteria to multiply (Ternes, and Joss, 2007; 
Beers et al, 2003). 
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2.2.1.4 Sulphonamides 
Sulphonamides (SA) are synthetic antimicrobial with a wide spectrum against most 
gram-positive and many gram-negative organisms. The term “sulphonamides” is a 
monomer as it includes the amides of all organic sulfonic acids, but only the amides 
of sulfanilic acid (para-aminobenzoesulfonic acid) exhibit antibacterial activity. 
Sulfonamides are bacteriostatic agents, i.e. they block bacterial growth, but 
cooperation of the host immune defense is required to eradicate an infection. 
Therefore, molecular structure of sulfonamide is similar to p-aminobenzoic acid 
(PABA) which is needed in bacteria organisms as a substrate of the enzyme 
dihydropteroate synthetase for the synthesis of tetrahydrofolic acid (THF). 
Sulfonamides, derived chiefly from sulfanilamide, are capable of interfering with the 
metabolic processes in bacteria that require PABA. They act as antimicrobial agents 
by inhibiting bacterial growth and activity and called sulfa drugs. They are used 
in the prevention and treatment of bacterial infections, diabetes mellitus, edema, 
hypertension, and gout.  
Sulfonamides inhibit the multiplication of bacteria, because they are competitive 
inhibitors of p-amino benzoic acid in the folic acid metabolism cycle (O’Neil et al, 
2001), thus causes a decline in folate concentration. This decline is detrimental to the 
bacterium because folic acid is the precursor of purines and pyrimidines, the bases 
used in the construction ofDNA, RNA and other important cell constituents. The 
resulting inhibition of purine and pyrimidine synthesis leads to cessation of protein 
synthesis and DNA replication, thus the pathogen dies. 
Resistance against sulfonamides has been increasing because many formerly 
susceptible pathogens have developed an ability to take up folic acid from their 
environment while bacteria are initially are not able to synthesize their own folic 
acid, whereas most animals obtain folic acid from their own diet (Madison et al, 
2006). Nowadays sulfonamides are often used in fixed combinations with a 
diaminopyrimidine, either trimethoprim (TMP) (Ternes and Joss, 2007). 
Antimicrobial therapy with sulfamethoxazole plus trimethoprim, a related folic acid 
synthesis competitor, is still effective in many instances because the drug 
combination produces sequential blocking of the folic acid synthesis pathway. 
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approximately 45 % of SMX is excreted via urine (McEvoy et al, 2004). Monitoring 
data on raw and treated sewage from municipal wastewater treatment plants 
(WWTPs) indicated that the removal of sulfonamides during sewage treatment is 
incomplete, resulting in the discharge of antimicrobial residues into the receiving 
water bodies (Perez et al, 2005). 
2.2.1.5 Tetracyclines 
Tetracycline antibiotics are derived from a species of Streptomyces bacteria. They 
are broad-spectrum bacteriostatic agents, that inhibit bacterial protein synthesis. 
Tetracyclines may be effective against a wide variety of microorganisms, including 
rickettsia and amebic parasites (Url-5 and Url-6, 2012). 
2.2.1.6 Aminoglycosides 
Aminoglycosides are derived from various species of Streptomyces genus. 
Aminoglycoside antibiotics are used to treat infections caused by gram-negative 
bacteria. Aminoglycosides may be used along with penicillins or cephalosporins to 
give a two-pronged attack on the bacteria. (Beers et al, 2003).In summary, most 
commonly used types of antibiotics are shown in Table 2.1. 
Table 2.1 : Classification of antibiotics. 
Class 
(chemical structure) Action mechanism Examples 
B-lactam antibiotics  
 
Inhibit bacterial cell 
wall synthesis  
 Penicillins  
 Cephalosporins  
 Carbapenem  
Macrolides  Inhibit bacterial protein synthesis 
 Erythromycin 
 Azithromycin  
 Clarithromycin  
Fluoroquinolones  Inhibit bacterial DNA synthesis 
 Norfloxacin  
 Ciprofloxacin  
 Enoxacin  
 Ofloxacin  
Sulphonamides 
Blocks bacterial cell 
metabolism by 
inhibiting enzymes 
 Co-trimoxazole  
 Trimethoprim/Sulfamethoxazole 
Tetracyclines 
Inhibit bacterial 
protein synthesis 
 Tetracycline  
 Minocycline  
 Doxycycline 
Aminoglycosides Inhibit bacterial protein synthesis 
 Gentamicin  
 Amikacin  
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2.2.2 Significance of antibiotics in the environment 
Antibiotics have been detected in various compartments of the environment such as 
in sewage, surface, ground and drinking waters or in soil (Kümmerer 2003). 
According to data supplied by the European Federation of Animal Health (FEDESA) 
in 1999, 13 288 tons of antibiotics were used in the European Union (EU) and 
Switzerland, of which 65% was used in human medicine; 29% was used in the 
veterinary field and 6% as growth promoters. 
In 1996, about 10 200 tons of antibiotics were used in the EU, of which 
approximately 50% was applied in veterinary medicine and as growth promoters. 
Several hundred different antibiotic substances are used in human and veterinary 
medicine, e.g. more than 250 in Germany (Kümmerer and Henninger, 2003). In the 
USA, approximately 16 200 tons were produced in 2000 of which 70% was used in 
livestock farming. This is eight times of the amount used in human medicine. Wise 
estimated total world-wide antibiotic consumption is lie between 100 000 and         
200 000 tons (Kümmerer, 2003). 
Consumption for humans in total, per capita and the individual share of each 
compound varies from country to country. In total, 412 ton of antibiotics were used 
in Germany 1998. Taking the compound specific metabolization rates into account, 
305 ton are emitted into wastewater, of which 92 ton were due to hospitals. The data 
demonstrate that there are no point sources but diffuse input by the general 
public/wastewater treatment plants(Kümmerer and Henninger, 2003). 
Consumption by animals for the purposes of prevention or therapy is largely 
determined by modern animal breeding and fattening methods and conditions. 
Antibiotics are also used to promote the growth of animals (Gaskins et al, 2002) in 
some countries where they are used at low doses in animal feeds and are considered 
to improve the quality of the product, with a lower percentage of fat and higher 
protein content in the meat (Cromwell, 2002). 
Antibiotics have been used since the 1950s to control certain bacterial diseases of 
high-value fruit, vegetable, and ornamental plants. Today, the antibiotic, which is 
most commonly used on plants, is streptomycin with oxytetracycline to a minor 
extent (Kümmerer, 2009a). In aquaculture, antibiotics have been used mainly for 
therapeutic purposes and as prophylactic agents. Antibiotics authorized for use in 
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aquaculture are oxytetracycline, florfenicol, premix, sarafloxacin, erythromycin, 
sulphonamides potentiated with trimethoprim or ormethoprim (Serrano, 2005). 
Antibiotics are also used in aquaculture, for the purpose of preventing or treating 
microbial infections (Kümmerer and Henninger, 2003). High loads of antibiotics in 
sediments at concentrations potent enough to inhibit the growth of bacteria have been 
reported for aquaculture. Resistant bacteria may be present in sediments because of 
the application of antibiotics in fish farming or because of selection through the 
antibiotics present in the sediments 1990s (Kümmerer, 2009b). Some investigations 
have demonstrated the presence and persistence of antibiotics applied extensively in 
fish farming in sediments beneath fish farms (Kümmerer et al, 2004). 
Fluoroquinolones, sulphonamides and tetracyclines are strongly adsorbed; therefore 
they can readily accumulate in sediments. 
2.2.3 Resistance of antibiotics in the environment 
Antibiotics have been reported in hospital wastewaters, wastewater treatment plant 
(WWTP) effluents, WWTP biosolids, soil, surface waters, groundwaters, sediments, 
biota and drinking water (Watkinson et al, 2009). The development and proliferation 
of antibiotic resistance in pathogenic, commensal, and environmental 
microorganisms is a major public health concern (McMahon et al, 2007). Resistant 
and even multi-resistant pathogenic bacteria have been detected in wastewater, as 
well as in other environmental compartments because of lots of natural processes. 
The municipal wastewater may be polluted by antibiotics due to the human 
excretions. Most antibiotics are not completely metabolized or eliminated in the body 
and between 30 and 90 % are discharged unchanged into the sewage system (Hirsch 
et al, 1999). Another study has shown that the non-metabolized fraction of antibiotics 
is excreted approximately 70% of the totals in Germany as a still-active compound 
(Kümmerer and Henninger, 2003). If the drugs are not degraded or eliminated during 
sewage treatment, in soil or in other environmental compartments, they will reach 
surface water and ground water and, potentially, drinking water. For instance, 
sulfamethoxazole concentration in the surface waters was measured between 30 and 
85 ng/Lin Germany. Unmetabolized antibiotic substances are often passed into the 
aquatic environment. Therefore, this allows resistant bacteria to enter the food chain 
directly (Figure 2.3) (Kümmerer, 2003). It might reach humans again via drinking 
water. Furthermore, direct discharge, especially from poultry processing, meat 
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The widely detection of antibiotic containing compounds in water resources has 
became increasing concern because of their contribution to the presence and 
persistence of resistance in populations of both pathogenic and non-pathogenic 
microbes (Kolpin et al, 2002). Bacteria resistant to antibiotics have been found in the 
aquatic environment (Kümmerer et al, 2004; Kim and Aga, 2007; Watkinson et al, 
2007) and in soil (Schmidt and Römbke, 2008). In addition, antibiotic-resistant 
bacteria were detected in drinking water as early as the 1980s and later in the 1990s 
(Kümmerer, 2009b). 
Resistance of antibiotics is one of the major challenges for human medicine and 
veterinary medicine (Kümmerer, 2009b). The excretion from medicated animals and 
the application of the contaminated manure on agricultural land are among the major 
routes by which veterinary antibiotics enter the environment. Pharmaceutically active 
ingredients are complex molecules with different functionalities and physico-
chemical and biological properties. They can have undesired effects on non-target 
organisms present in the environment (Kümmerer, 2009a), since they have been 
designed to cause damage in DNA of bacteria or to eukaryotic cells. 
To understand the ecology of antibiotic resistance, it is necessary to characterize the 
occurrence, fate, and transport of antibiotic-resistant bacteria. A first step in this 
endeavour is the identification of major sources of antibiotics and antibiotic 
resistance to the environment. Resistant bacteria may be detected by antibiotic 
substances in hospital effluent, municipal sewage, aeration tanks or the anaerobic 
digestion process of WWTPs. The dilution of hospital effluents by municipal sewage 
will lower the concentration of antibiotics only moderately, because municipal 
wastewater also contains antibiotic substances and disinfectants from households, 
veterinary sources and to a minor extent from livestock. Antibiotics have been 
detected in the μg/L range in municipal sewage, in the effluent of wastewater 
treatment plants (WWTPs), in surface water and in groundwater. These included 
quinolones such as ciprofloxacin, sulphonamides, roxythromycin, dehydrated 
erythromycin and others. As the hospital effluents contribute to less than 1% of the 
total amount of municipal sewage (Kümmerer, 2008), it is plausible that hospitals are 
not the main source for resistant bacteria in municipal sewage. Resistant bacteria are 
also present in municipal sewage not receiving hospital effluent. Because of the use 
of antibiotics in the home, the conclusion is that it is probably the general community 
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that is responsible for the main input of resistant bacteria into WWTPs.Resistant and 
multi-resistant bacteria such as E. coli, P. aeruginosa, Acinetobacter, Pseudomonads, 
Enterobacteriaceae, and phylogenetically distant bacteria, such as members of α- 
and β-Proteobacteria, are present in municipal sewage as well as in the aeration 
tanks and the anaerobic digestion process of WWTPs. Resistance against b-lactams, 
quinolones, tetracycline and sulfamathoxazole/trimethoprim and other 
sulphonamides has been found in wastewater and sewage sludge all over the world 
using classical means such as cultivation and resistance testing as well as the 
detection of resistance encoding genes (Kümmerer et al, 2004).  
Another study also determined that between 16% and 35% of Escherichia coli 
isolates cultured from treated effluent were resistant to tetracycline (Reinthaler et al, 
2003). Additionally, the incidence of antibiotic resistance among culturable 
Escherichia coliin WWTPs and a large fraction (57%) of that were resistant to 
tetracyclines were reported (Reinthaler et al, 2003). 
A multi-resistant Acinetobacter strain which is known to be able to survive in sewage 
was introduced to a laboratory-scale sewage treatment plant (LSSTP) containing a 
mix of antibiotics at a concentration up to 100-fold above that expected in the aquatic 
environment in Germany and reflecting nation-wide antibiotic use. Furthermore, 2 
weeks after introduction of the bacterium into the treatment plant, the genetic 
material responsible for the multi-resistance could no longer be detected. These 
results suggest that the continuous input of resistant bacteria due to the application of 
antibiotics is by far much more important than the input of antibiotics (Kümmerer, 
2009b).  
Moreover, antibiotics were recently classified as a priority risk group due to their 
high toxicity to algae and bacteria at low concentrations and their potential to cause 
resistance amongst natural bacterial populations. The sensitivity of algae towards 
antibiotics varies widely. As algae are the basis of the food chain, even slight 
decreases in the algal population may affect the balance in an aquatic system. Blue-
green algae (Cyanobacteria) seems to be sensitive to many antibiotics, for example 
amoxicillin, benzyl penicillin, sarafloxacin, spiramycin, tetracycline and tiamulin 
(Boxall et al, 2003). The presence in surface waters of antibiotics is often reported in 
lower concentration level (low ng/L) and several publications about 
sulfamethoxazole, erytromicyn evidencing the frequency of both drugs in the aquatic 
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compartment (Hernando et al, 2006). Similarly, antibiotics were detected quite 
frequently in the low ng/L range, up to 2 μg/L in the surface waters of six 
investigated rivers including freshwater, estuarine and marine samples (Watkinson et 
al, 2009).Hence, antibiotics in surface waters have the potential to disrupt key 
bacterial cycles/processes critical to aquatic ecology (nitrification/denitrification) or 
agriculture (soil fertility) and animal production (rudimentary processes) (Watkinson 
et al, 2009). 
2.3 Removal of Antibiotics 
Antibiotics are considered highly toxic to the environment and to human life and 
therefore have to be removed from contaminated waters and wastewaters to the 
highest possible extent. Wastewater usually contains antibiotics either as excretion 
products resulting from metabolism or as a consequence of the inaccurate disposal of 
unused or out-of-date drugs. In wastewater treatment plants (WWTPs), a 
pharmaceutical compound and its metabolites may undergo a partial or complete 
mineralization, a slow biodegradation after binding on solid sludge, or may pass 
unchanged through the wastewater treatment plants. A number of drugs have been 
detected both in sewage and in WWTP effluents from various sources, with levels 
ranging from below detection limits up to mg/L and with removal efficiencies 
ranging widely depending on their physical chemical characteristics (Carucci et al, 
2006). These substances are usually removed from wastewaters by biological 
processes, among which the activated sludge process is applied as the most common 
treatment method. In principle, they can be removed in the activated sludge process 
through different mechanisms: biodegradation, volatilisation, air stripping or 
adsorption on primary or secondary sludge (Dionisi et al, 2006). 
Antibiotics may be removed in WWTPs by transformation processes such as 
hydrolysis, chlorine or ozone oxidation, and aerobic or anaerobic biodegradation. 
Varying degrees of transformation depend upon the nature of the compound, and the 
specific conditions and processes existing within the treatment plant. A key issue 
associated with any transformation process is that the parent compound is rarely 
mineralized (e.g., converted to inorganic carbon, nitrogen, phosphorus, etc.) 
Numerous studies have suggested that, in general, sorption of PPCPs to biosolids, 
aerobic biodegradation, membrane processes, and disinfection with chlorine or 
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ozone, may each provide for significant removals of many PPCPs under certain 
common treatment conditions (Adams, 2008). 
Elimination of antibiotic compounds in the environment is the result of different 
processes. These processes can be biotic ones, i.e. biodegradation by bacteria and 
fungi. Non-biotic elimination processes are sorption, hydrolysis, photolysis, 
oxidation and reduction. It has to be noted that the results of bio-or photodegradation 
studies depend on conditions such as temperature, composition of matrix, latitude 
etc. (Kümmerer, 2009a). 
Different studies on fate of antibiotics after treatment highlighted three different 
ways for antibiotics disappearance. The most favourable case is biodegradation, 
another way is accumulation on biomass defined as biosorption, which leads to the 
release of molecules after biomass death, and a third way is hydrolysis (Amrane et al, 
2009). The main removal mechanisms of antibiotics are given below in detailed. 
2.3.1 Sorption 
Sorption was found to be the main mechanism of antibiotics removal by the activated 
sludge, this mechanism has been studied in more detail with the aim of determining 
the sorption equilibrium and kinetics, in order to provide useful data for the 
modelling of the fate of them in biological wastewater treatment. Sorption was found 
to be a very fast mechanism of organic substance removal from the liquid phase, and 
only a few minutes were needed to reach 90% of the final sorption for most of the 
substances (Dionisi et al, 2006). 
Contaminants present in wastewater can partition between the liquid and solids 
phase, with sorption onto dissolved and colloidal organic matter (DCOM). This can 
subsequently influence the availability of contaminants for biodegradation. 
Mechanisms other than hydrophobic partitioning, such as cation exchange, cation 
bridging, surface complexation, and hydrogen bonding can have a significant impact 
on sorption (Plosz et al, 2010). 
Binding to particles or the formation of complexes may cause a loss in detectability, 
as well as a loss in antibacterial activity. The loss of antibacterial activity, for 
example, was demonstrated for an aquaculture antimicrobial in seawater driven by 
the formation of complexes with the magnesium and calcium naturally present in 
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marine water. For instance, tetracyclines are able to form complexes with double 
cations, such as calcium or magnesium (Christian et al, 2003).  
2.3.2 Photolysis 
If a substance is light sensitive, photo-decomposition may be of major significance in 
the elimination process. Photo-decomposition takes place mainly in clear surface 
water. Photochemical decomposition can play an important role in surface water as 
an additional elimination pathway or for effluent treatment (Kümmerer, 2009a). 
Some antibiotics are light sensitive (e.g. quinolones, tetracyclines, sulphonamides, 
tylosin, nitrofuran antibiotics). However, not all compounds are photo-degradable. 
Antibiotics may be degraded abiotically via photodegradation and/or hydrolysis or 
biotically by aerobic or anaerobic organisms. The quinolones and tetracyclines are 
rapidly photodegraded with half-lives ranging from <1 h to 22 d. In contrast, 
trimethoprim and sulfonamides are not readily photodegradable (Kümmerer, 2009a).  
2.3.3 Hydrolysis and thermolysis 
Another important pathway for the non-biotic elimination of organic substances in 
the environment is hydrolysis. In general, the hydrolysis rates for oxytetracycline 
increase as the pH deviates from pH 7 and as temperature increases. However 
sulphonamides and quinolones are resistant to hydrolysis. In laboratory 
biodegradability testing with sewage sludge, it has been found that β-lactams are 
rapidly hydrolysed. This leads to the deactivation of antibiotic activity (Längin et al, 
2009). 
Hydrolysis of particulate and colloidal organic matter along with biodegradation of 
the soluble mostly readily biodegradable substrates (SS) can therefore influence the 
biodegradation of compounds such as antibiotics in WWTPs. In activated sludge, it 
is also possible that certain metabolites of pharmaceuticals can be transformed back 
to the parent compound as a result of enzyme-catalyzed reactions (Plosz et al, 2010). 
2.3.4 Technical oxidation processes 
Antibiotic formulation effluents are well known for the difficulty of their elimination 
by traditional biological treatment methods and their important contribution to 
environmental pollution is due to their fluctuating and recalcitrant nature. For 
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advanced effluent treatment oxidation processes are usually applied (Kümmerer, 
2009a). The effect of ozonation on the degradation of oxytetracycline in aqueous 
solution at different pH values (3, 7 and 11) was investigated by Li et al. (2008). It 
has been shown that COD (chemical oxygen demand) removal rates increase with 
increasing pH as a consequence of enhanced ozone decomposition rates at elevated 
pH values. The results of bioluminescence data indicate that the initial by-products 
after partial ozonation (5–30 min) of oxytetracycline were more toxic than the parent 
compound. 
On the other hand, sulfamethoxazole was efficiently degraded by ozonation (Dantas 
et al, 2007). A biodegradability enhancement expressed as the increment of 
BOD5/COD (biological oxygen demand after 5 d/chemical oxygen demand) ratio 
from 0 to 0.28 was observed by the authors after 60 min of ozonation. The complete 
sulfamethoxazole removal was achieved for an in photo-Fenton process (González et 
al, 2007). 
2.3.5 Biodegradation 
Most antibiotics tested to date have not been biodegradable under aerobic conditions 
(Richardson and Bowron, 1985; Al-Ahmad et al, 1999; Wiethan et al, 2000; 
Kümmerer et al, 2000; Ingerslev and Halling-Sørensen, 2001; Gartiser et al, 2007; Li 
et al, 2008). The biodegradability of some clinically important antibiotic drugs 
(ciprofloxacin, ofloxacin, metronidazole) and hereby the elimination of their 
genotoxicity was investigated as the first step of an environmental risk assessment 
using the Closed Bottle Test (CBT) (OECD 301 D). The CBT is simple test for the 
assessment of the biodegradability of organic compounds and the standard test period 
of the CBT is 28 days (Kümmerer et al, 2000). According to this test, it has been 
determined that sulfamethoxazole was stable during the test period of 28 days and 
seen to be resistant to biodegradation (Gartiser et al, 2007). 
Biodegradability tests were conducted on SMX as Zahn WellensTest (OECD 302B) 
and CO2 Evoluation Test (OECD 301B). Zahn Wellens Test (DOC elimination 
based) and CO2 Evoluation Test indicated inherent biodegradability and readily 
biodegradability, respectively whereas their combination results were used to assess 
inherent biodegradability and DOC elimination by sorption. The results showed that 
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SMX had no ultimate biodegradation (< 20 % removal) and only minor DOC 
elimination (< 20 % removal) in inherent tests (Gartiser et al, 2007). 
Biodegradability has been poor for most of the compounds investigated in laboratory 
tests such as the OECD test series (301– 303, 308) even for some of the ß-lactams 
(Alexy et al, 2004). Out of 16 antibiotics tested, only benzyl penicillin (penicillin G) 
was completely mineralized in a combination test (combination of the OECD 302 B 
and OECD 301 B tests; Gartiser et al, 2007). No evidence of biodegradation for 
tetracycline was observed during a biodegradability test (sequence batch reactor), 
and sorption was found to be the principal removal mechanism for tetracycline in 
activated sludge (Kim et al, 2005). Some antibiotics occurring in soil and sediment 
proved to be quite persistent in laboratory testing as well as in field studies. Some do 
not biodegrade well under anaerobic conditions (Gartiser et al, 2007). 
2.4 Enzyme Reactivity and Inhibition 
2.4.1 Conceptual approach of enzymes in biological processes 
All organisms control its activity through enzymes, which are protein molecules 
produced by microorganisms that catalyze chemical reactions. Enzymes comprise the 
largest and most specialized group of protein molecules within the cell (Rittmann 
and McCarty, 2001).The basic function of an enzyme is to increase the rate of a 
reaction rate by lowering the activation energy of the biochemical reaction (Orhon 
and Artan, 1994). Most cellular reactions occur about a million times faster than they 
would in the absence of an enzyme. Most enzymes act specifically with only one 
reactant (called a substrate) to produce products. Since enzymes are selective for 
their substrates and speed up only a few reactions from among many possibilities, the 
set of enzymes made in a cell determines which metabolic pathways occur in that 
cell (Orhon and Artan, 1994).The reactivity of an enzyme toward a substrate 
involves specificity and kinetics. The conventional view is that a substrate molecule 
or a portion of it fits into the active site of the enzyme in a lock-and-key model. 
Figure 2.4 shows the induced fit hypothesis of enzyme action. (Rittmann and 
McCarty, 2001). 
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L. Michaelis and M. L. Menten recognized this saturation phenomenon and, in 1913, 
developed a general theory of enzyme action and kinetics, which was later extended 
by G.E. Briggs and J.B.S. Haldane (Rittmann and McCarty, 2001). This theory 
suggest that enzyme E first reacts with substrate S to form an enzyme-substrate 
complex ES, which then breaks down to form free enzyme and products P. As a 
result ofreactions totake place, the coefficient KM, which represents a composite of 
the various rate coefficients, is called the Michaelis-Menten coefficient. Equation 
(2.1) is the Michaelis-Menten equation, which defines the quantitative relationship 
between the substrate concentration and the reaction rate in relation to the maximum 
possible rate. The coefficient KM equals the substrate concentration at which the 
velocity of the reaction is one-half of the maximum velocity. KM represents the 
affinity between the substrate and the enzyme. A low value of KM indicates a very 
strong affinity, such that the maximum rate is reached at a relatively low substrate 
concentration. A large value of KM, on the other hand, shows a poor affinity 
(Rittmann and McCarty, 2001). 
m
M
S = 
K +S
   (2.1)  
The Michaelis-Menten mechanism for the catalysis of biological chemical reactions 
is one of the most important chemical reaction mechanisms in biochemistry. It 
provides a practical tool to mathematically explain the behavior of microbial cultures 
under inhibitory effects (Rittmann and McCarty, 2001). 
2.4.2 Conceptual approach on enzyme inhibition 
Since biological processes deal with living organisms, they are subject to upsets by 
inhibitory or toxic agents. Inhibition is caused by chemical or physical agents, such 
as pH, temperature, oxidation-reduction potential of the medium, etc. So far two 
concepts have emerged, namely inhibition and toxicity. In the context of biological 
wastewater treatment, inhibition is defined as impairment of the enzymatic system of 
the living cell or direct damage to the cell structure, resulting in the slowing down of 
the cell activity. When the inhibited biochemical reactions are vital to the cell then 
the agent is identified as toxic. The effect of toxicity is manifested in 
microorganisms’ increased difficulty to take up nutrients and a decrease in growth 
rate or in the ultimate death of the cell. Translating this to the treatment system, a 
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lower degradation rate is observed and biomass activity is usually also altered 
(Orozco, 2008). 
The kinetic expressions in biological transformations can be based on the 
mechanisms of enzyme kinetics that led to the Michaelis-Menten expression. These 
enzymatic mechanisms can be extended to cover special circumstances such as the 
intrusion of inhibitory compounds, which interfere with the active enzymes rendering 
them unfit for product formation (Orozco, 2008).  
Inhibitory agents reduce enzyme reactivity, which is one way in which toxic 
chemicals can adversely affect a biological treatment process. For example, the 
chemical agent does not destroy the enzyme, and the reactivity can be reversed if the 
agent is removed. Two common types of reversible inhibition are competitive and 
noncompetitive inhibition (Rittmann and McCarty, 2001). 
2.4.2.1Competitive inhibition 
In competitive inhibition, a chemical that is similar in structure to the normal enzyme 
substrate competes with the substrate for the active site on the enzyme. Competitive 
inhibition defines the case where substrate, S, and inhibitor, I, compete for the same 
enzymatic site; the inhibitor can take the place of the substrate to form an enzyme 
inhibitor complex (EI), which cannot undergo further reactions with the  substrate 
(Orhon and Artan, 1994).  In competitive inhibition the maximal rate of the reaction 
is not changed, but higher substrate concentrations are required to reach a given 
maximum rate. A competitive inhibition model, developed from fundamental 
principles is; 
m
M
I
S = 1K (1+ )+S
K
   
(2.2)  
Where I is the concentration of the competitive inhibitor, and KI is a competitive 
inhibition coefficient having the same concentration units as I. As I increases, the 
rate decreases in a manner similar to that as if KM were increased in Equation (2.1). If 
S is large enough, the inhibitor is removed from the active site, and the maximum 
rate of substrate transformation is achieved (Rittmann and McCarty, 2001) (Figure 
2.6). 
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Figure 2.6: Competitive inhibition (Url-4, 2011). 
In addition, competitive inhibition has often been observed between the growth and 
co-metabolic substrates. Co-metabolism is the biological transformation of a non-
growth (co-metabolic) substrate by bacteria through enzymes which can only be 
induced in the presence of a growth-substrate providing energy for cell growth and 
maintenance. In recent years, specific organic chemicals have become of concern and 
the goal is often to reduce concentrations to the low microgram per litre level, or 
even lower. Lower limits can also be achieved by proper design of treatment systems 
that base on the principle of co-metabolism (McCarty, 2000). 
In generally, the aerobic co-metabolism is catalyzed by nonspecific oxygenase 
enzymes that use molecular oxygen as the electron acceptor and NAD(P)H as the 
reducing energy to oxidize both growth- and non-growth substrates (Chang and 
Alvarez-Cohen, 1995 a, b). Non-growth substrates have a similar structure to 
growth-substrates and can bind to enzymes and be transformed due to non-specific 
activity. However, some factors such as the inhibitory effects of the initial growth-
substrate or co-metabolic substrate on the enzyme as well as the inhibitory effects of 
products and limitations in NAD(P)H generation may adversely affect the 
degradation. As shown in Figure 2.7, short-lived toxic intermediate products may 
cause damage on oxygenase enzyme or cell. In this case, co-metabolic oxidation of 
the non-growth substrate consumes the reductant NAD(P)H which is then not 
regenerated (Figure 2.7). Thus, NAD(P)H, which is a potentially limiting reactant 
during co-metabolic reactions, must be provided by external or endogenous 
regenerants. 
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     Figure 2.7 : Typical oxygenase enzyme reactions for growth-substrate and co 
metabolic (non-growth) substrate (Chang and AlvarezCohen,1995b). 
The products of growth-substrate oxidation may undergo further degradation that 
regenerates NAD(P)H for additional substrate oxidations. Therefore, it is essential 
that a growth-substrate is provided at least periodically for growth of new cells and 
induction of enzyme production. Co-metabolic degradation occurring in the absence 
of external regenerants is referred to as the resting cells condition. In this case, the 
reducing energy can only be provided by endogenous energy sources or general 
biomass that often limits the co-metabolic degradation rate and leads to product 
toxicity (Chang and Alvarez-Cohen, 1995b) (Çeçen et al, 2010). 
2.4.2.2 Noncompetitive inhibition 
In noncompetitive inhibition, the chemical agent acts by complexing a metallic 
activator or by binding at a place on the enzyme other than the active site. The 
enzyme is then less reactive toward its substrate. The inhibition reaction cannot be 
reversed by raising the substrate concentration. The substrate is then unable to 
prevent the combination of the inhibitor with the enzyme. The magnitude of 
inhibition will accordingly depend on I and K1, and it will not be infuenced by S or 
ES (Figure 2.8) (Orhon and Artan, 1994). A noncompetitive inhibition, developed 
from fundamental principles is; 
m
M
I
S 1 =  . ( )1K +S 1+
K
   
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2.5 Researches on the Biodegradation of Sulfamethoxazole in Activated Sludge 
Process 
The activated sludge process is a biological method of wastewater treatment that is 
performed by mixed microbial cultures in an aerobic aquatic environment. These 
microorganisms derive energy from carbonaceous organic matter in aerated 
wastewater for the production of new cells in a process known as synthesis, while 
simultaneously releasing energy through the conversion of this organic matter into 
compounds that contain lower energy, such as carbon dioxide and water, in a process 
called endogenous respiration. This consortium of microorganisms, the biological 
component of the process, is known collectively as activated sludge (Metcalf and 
Eddy, 2004).  
The higher removal efficiency of antibiotics has been reported in the activated sludge 
process under aerobic conditions in compared to anaerobic conditions. Although, the 
removal of antibiotics from wastewater was the highest in the aerobic system and in 
the combined anaerobic and aerobic system, antibiotic concentrations after anaerobic 
treatment indicated their overall poor removal (Leal et al, 2010). 
Most of antibiotics come either from domestic sewage or from hospital or industrial 
discharges and enter WWTPs. Modern WWTPs can effectively accomplish carbon 
and nitrogen removal, as well as microbial pollution control. However, urban 
WWTPs normally receive streams that contain a lot of different trace polluting 
compounds (synthetic and natural), for which conventional treatment technologies 
have not been specifically designed. Their removal efficiencies are influenced, apart 
by the chemical properties of specific compounds, by microbial activity and 
environmental conditions (Omil et al, 2004). A major factor influencing the 
efficiency of these pollutants removal from water is their ability to interact with solid 
particles, both natural (clay, sediments, microorganisms) or added to the medium 
(active carbon, coagulants), because this facilitates their removal by physical - 
chemical (settling, flotation) or biological processes (biodegradation). However, 
some compounds with low adsorption coefficients tend to remain in the aqueous 
phase, which favors their mobility through the sewage treatment plant (STP) and the 
receiving environment (Omil et al, 2004). This leads to inhibition of the microbial 
processes. Therefore, for determination of most efficient treatment strategies, it is 
important to understand the role of enzymes and inhibition mechanism as well as the 
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treatment behavior of antibiotics with other carbon sources. Omil et al.(2004) has 
investigated that the treatment of sulfamethoxazole has been surveyed along the 
different units of a municipal STP with a population of approximately 100 000 
inhabitants in Spain. The plant includes three main sections: pre-treatment, primary 
treatment and secondary treatment. Sulfamethoxazole was quantified with 
concentrations of around 0.6 μg/L in these wastewaters, which is removed around 
67%, during the biological step. 
Another study by Perez et al. (2005) has showed that the synthetic antimicrobials 
sulfamethazine, sulfamethoxazole, sulfathiazole, and trimethoprim have the potential 
to be microbially degraded during sewage treatment. The biodegradability tests were 
conducted in aerated batch reactors by spiking the sewage with 20 mg/L of each of 
the test substance. Concentration profiles of the assayed compounds were monitored 
during a 54 days period using liquid chromatography/electrospray ionization/mass 
spectrometry. The highest degradation rates were obtained in the sewage from the 
activated sludge treatment, where no adaptation phase was observed. On the other 
hand, the onset of biodegradation in the sewage from the primary treatment was 
preceded by a lag phase ranging from 10 to 15 days.  
The occurrence of antibiotics in WWTP effluents has been also carried out in several 
studies. Sulfamethoxazole was also found in raw influent and final effluent, 
indicating that it could withstand different treatment processes in the STPs (Xu et al, 
2007). Sulfamethoxazoleand trimethoprim or erythromycin are often founded at 
medium - high ng/L level (128 and 886 ng/L) (Hernando et al, 2006). Investigated 
WWTPs were highly effective in removing antibiotics from the water phase, with an 
average removal rate of greater than 80% for all targeted antibiotic. However, 
antibiotics were still detected in WWTP effluents in the low ng/L range up to a 
maximum of 3.4 μg/L, with the macrolide, quinolone and sulphonamide antibiotics 
most prevalent.  
The sulphonamides all demonstrated high removal in WWTP effluent (roughly 80%) 
with the tetracyclines only demonstrating little removal (roughly 30%) from the 
water phase. The highest recorded antibiotic concentration in WWTP effluents was 
tylosin (3.4 μg/L); however, sulfamethoxazole had the greatest median value (0.05 
μg/L) (Watkinson et al, 2009).  
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In addition, the fate of sulfamethoxazole in the activated sludge process was studied 
using a sequencing batch reactor. According to study, SMX serves as a carbon and/or 
a nitrogen source for the enhanced culture of microorganisms that are able to degrade 
it (Drillia et al, 2005). Drillia et al. also investigated the removal of SMX in presence 
of excess ammonium and readily biodegradable carbon source (acetate), which is a 
common situation at wastewater treatment plants. It has been found out that under 
these conditions, the enzymes responsible for the removal of the antibiotic were 
inactivate, and that if enough time was given for the synthesis of these enzymes, 
degradation of SMX was also possible under ammonium rich conditions. According 
to the results obtained from the study, it has been concluded that SMX can be 
removed in systems like extended aeration systems, where there is an absence of a 
readily biodegradable substrate. 
The example treatment strategies and efficiencies of different antibiotics in WWTPs 
are summarized in Table 2.2 (Avella et al, 2010). 
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Table 2.2: The fate of different antibiotics in WWTPs and in hospital effluents (Avella et al, 2010). 
Antibiotic WWTP Antibiotic Influent (ng/L) 
Bioreactor 
(ng/L) 
Secondary 
Effluent 
(ng/L) 
Hospital 
Effluents (ng/L) Comments 
Erythromycin Erythromycin: macrolide antibiotic. Macrolides were the second antibiotic class 
mostly used in human care in european countries between 1998–2005 (ESAC). 
Erythromycin is usually applied for respiratory tract infections, infections of soft 
tissues and when infections are persistent to penicillin antibiotics. Its principal 
metabolite Erythromycin-H2O is the mostly frequently detected macrolide antibiotic 
in WWTP effluents (Watkinson et al, 2009). This indicates its potential to pass 
through conventional treatment (Hirsch et al 1999). The elimination of Erythromycin 
in conventional WWTP is incomplete. 
Gulkowska et al. (2008) 470-810    
Göbel et al. (2005) 70 ±120  80±60  
Roxithromycin
Roxithromycin: macrolide antibiotic. It is better tolerated by human than 
Erythromycin. Göbel et al. (2005) observed that Roxithromycin was persistent in the 
effluent from WWTP with conventional activated sludge treatment. They reported 
that no significant sorption of this antibiotic was detected on biological sludge 
Watkinson et al. (2007) 0-18 0-60 0-100  
Watkinson et al. (2009) ~ 8  ~ 20 ~ 50 
Göbel et al. (2005) 20±20  20±10  
Sulfamethoxazole
Sulfamethoxazole: In conventional WWTP, the elimination of Sulfamethoxazole 
was found to be incomplete. Therefore, it is frequently detected in rivers. In 
sequencing batch reactor, Drillia et al. (2005) suggested that bacteria used 
Sulfamethoxazole as a nitrogen source when more readily biodegradable source of 
nitrogen was absent. Göbel et al. (2005) reported the sorption of Sulfamethoxazole 
on biological sludge. 
Watkinson et al. (2007) 360-500 185-200 270-320 1300-2100 
Brown et al. (2006)    400-2100 
Watkinson et al. (2009) 250±2750  50±150 100±200 
Göbel et al. (2005) 430±200  280±560  
Amoxicillin  
Amoxicillin: penicillin antibiotic class. The penicillin was the most consumed 
antibiotic in EU (ESAC, 1998–2005). Amoxicillin belongs to b-lactams (cyclic 
amide) which are not generally considered as important environmental pollutants 
because they undergo thermal degradation until ultimate mineralisation to CO2 and 
water (Hirsch et al, 1999). 
Watkinson et al. (2007) 190-280  0-30  
Watkinson et al. (2009) ~ 1400  <50 90 
Tetracycline      
Tetracycline undergoes photochemical degradation and forms a number of 
degradates products. Many of them are highly soluble and stable in receiving waters. 
Tetracycline has also a tendency to form relatively stable complexes with double 
cations such as calcium and magnesium and with particulates matter (Halling-
Sorensen et al, 2002). Tetracycline removal of water phase is not complete 
(Watkinson et al, 2009). However, Tetracycline is eliminated by more than 50% due 
to sorption on sewage sludge (Watkinson et al, 2007). 
Watkinson et al. (2007) 0-35 0-20 0-30  
Watkinson et al. (2009) <10  <20 <40  
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2.6 Modelling of Activated Sludge Systems 
Different mathematical models have already been developed to describe the process 
kinetics of microorganisms in an activated sludge process during the aerobic 
biodegradation of slowly as well as readily biodegradable substrates. Proper 
understanding of substrate removal mechanisms in activated sludge plants is very 
essential for modelling purposes. Thus, modelling of aerobic biodegradation of 
substrates has been continuously evolving that enables improved interpretation of the 
process kinetics of substrate removal mechanisms in activated sludge processes. The 
trend of improving the effluent quality from wastewater treatment plants leads to an 
increasing complexity in the design and operation of the plants. To design the plants 
and optimize and control the operation, it is necessary to use dynamic models 
(Henze, 2005). 
Deterministic models are the most used in wastewater treatment plant design. The 
deterministic models, also known as black-box type models that are used for 
controlling purposes, aim to give a realistic description of the main processes of the 
plant. However, models are never true in the process sense and always simplify the 
complicated processes occurring in a biological treatment plant. A major gap in 
deterministic modelling is lack of knowledge about the development of the 
microbiology in treatment plants (Henze, 2005). For this reason, it is commonly 
agreed that the only way to provide a reliable basis for design and operation of 
treatment plants is to identify a rational mechanistic description of the process in 
terms of microbial kinetics and material balance (Orhon and Artan, 1994).  
Mechanistic models would provide a reasonably acceptable description of major 
biochemical processes in terms of microbial kinetics and stoichiometric relationship 
among significant parameters. Models developed can only provide a simplified 
approximation of complex biochemical reactions taking place in the activated sludge 
systems (Orhon et al, 2009a). 
A new conceptual approach of wastewater characterization relies on the existence 
and identification of a number of substrate fractions with different biodegradation 
characteristics. This approach also differentiates active biomass from other 
particulate biomass components (Orhon et al, 2009a). Compared with traditional 
models (Pearson, 1968; Jenkins and Garrison, 1968; Lawrence and McCarty, 1980) 
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having only two components (substrate/biomass) and two processes (growth/decay), 
the number of model components is increased to account for all significant substrate 
and biomass fractions (Orhon et al, 2009a). 
A mechanistic model should include a minimum eight components for the modelling 
of organic carbon removal. They can be divided into two groups: substrate 
components and biomass components. The readily biodegradable COD, SS, the 
slowly biodegradable COD, XS, the soluble inert COD, SI and the particulate inert 
COD, XI define the biodegradation characteristics of the wastewater. The rapidly 
hydrolysable COD, SH is often considered as an additional model component for 
most wastewaters. The major biomass components obviously include active 
heterotrophic biomass, XH, together with soluble and particulate inert microbial 
products, SP and XP. Dissolved oxygen concentration, SO is the indispensable 
parameter for the model (Orhon et al, 2009a). 
Most models for activated sludge processes are based on the IAWQ Activated 
Sludge Model No. 1, called ASM1 (Henze et al, 1987). This model is used as a 
platform for further modeling approachs and is today the international standard for 
advanced activated sludge modeling, although this model has been extended 
considering some important processes such as biological phosphorus removal 
(ASM2, Henze et al, 1994) and storage phenomena (ASM3, Gujer et al, 1999).  
2.6.1 Activated Sludge Model No. 1 (ASM1) 
The International Association on Water Quality (IAWQ, formerly IAWPRC) was 
established in 1983 for the development and application of practical models in 
activated sludge systems. After extensive studies, Activated Sludge Model No.1 
(ASM1) was developed by IAWQ Task Group with mathematical modelling for 
design and operation of biological wastewater treatment systems (Henze et al, 1987). 
ASM1 have still provided basis for the design and modelling of activated sludge 
systems. It is essential to have comprehensive knowledge on this first conceptual 
model ASM1, to understand all basic processes of activated sludge. ASM1 generally 
takes into consideration these three components: biomass, substrate and oxygen. The 
basic components and process of ASM1 for carbon oxidation is shown in Table 2.3. 
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Table 2.3: Processes for carbon oxidation described in ASM1 (Henze et al, 1987). 
Component SO SS XS XP XH
Process rate Process 
Growth  
H
H
Y
Y1  
HY
1   1 ˆ . .o SH H
o o S S
S S X
K S K S
           
 
Hydrolysis  1 -1   . .o S Hh H
o o X S H
S X Xk X
K S K X X
          
Decay   Pf1 Pf -1 HH Xb .  
Parameter O2 COD COD COD
Cell 
COD 
 
As seen from the simplified representation of ASM1, this model integrates two 
stoichiometric and six kinetic parameters to describe the utilization of wastewater by 
heterotrophic microorganisms. The biodegradable substrate in influent wastewater 
consists of two fractions: readily and slowly biodegradable substrate. Although, 
existing readily biodegradable substrate (SS) is assumed to consist of simple 
molecules which are able to pass through the cell wall and immediately be used for 
microbial growth, The slowly biodegradable substrate (XS), which consists of larger 
complex molecules, is adsorbed by activated sludge, and then broken down by 
extracellular enzymes (hydrolysis) before being transferred through the cell wall and 
used for metabolism. The processes of simplified ASM1 can be described as:  
 Growth: A fraction of the readily biodegradable substrate is used for growth 
of heterotrophic biomass and oxidized for energy requirement of the cell. The 
growth is modelled by using Monod kinetics. Both the concentration of SS 
and dissolved oxygen (SO) may be rate limiting for growth process. This 
process is generally the main contributor to the production of new biomass 
and removal of substrate.  
 Hydrolysis: Slowly biodegradable substrate (XS) is broken down to readily 
biodegradable substrate by extracellular enzymes, and then the latter one is 
available to the organisms for growth. This process is modelled on the basis 
of surface reaction kinetics. Therefore, the rate is expressed by first-order 
kinetic with respect to the present heterotrophic biomass. 
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 Decay: This process is modelled according to the death-regeneration 
hypothesis. Inert microbial product (XP) is generated during the lysis of 
heterotrophic microorganism (XH) with fraction fP. The remaining fraction of 
(1-fP) is transformed into XS. It is assumed that carbon is not removed during 
this transformation and as a consequence no electron acceptor is utilized. 
The main stoichiometric parameters represented in simplified ASM1 are the 
heterotrophic yield coefficient (YH) and fraction of biomass, leading to particulate 
product (fP). The coefficient fP, which is consumed as inert particulate product after 
decay process, is affected by the death-regeneration concept. If the decay process is 
modelled as endogenous decay, this value is usually assumed to be approximately 
0.2. However, the recycling of biomass by death-regeneration, results in significantly 
lower fP value in order to reach the same amount of particulate inert mass. YH is a 
stoichiometric constant known as observed growth yield. It is simply defined as 
weight of new biomass produced from the growth-limiting substrate. The yield term 
indicates the amount of substrate, which is used both for new biomass production 
and also for energy generation to carry out biosynthetic reactions (Ciggin, A.S, 
2011a). In addition, the YH is an important parameter, as it effects estimation of 
sludge production and oxygen demand; it also has an impact on kinetic parameters. 
As the YH highly depends on the biomass, it is assumed to be rather constant in 
different municipal wastewater treatment plants (WWTPs). The typical value of YH 
is given as 0.67 for municipal wastewaters in ASM1. 
Kinetic parameters are highly dependent on the nature of the substrate. Therefore, it 
is necessary to determine these parameters by case specific analyses. The interaction 
of different processes makes the determination of decay coefficient (bH) difficult 
related to the death regeneration concept. The maximum specific growth rate (μHmax) 
depends on the sludge ageand therefore depends on both characteristics of 
wastewater and operation of the WWTPs. The half saturation coefficient for 
heterotrophic biomass (KS) also depends on the operation of the WWTPs, due to the 
dependency of the floc size and structure on diffusion of substrate to the cell and 
thereby on the apparent value of saturation coefficients. The hydrolysis process in 
ASM1 is used to describe the degradation of slowly biodegradable organic substance 
originating from the influent carbon source and from internal turnover of substrate in 
the death regeneration cycle. In ASM1, the kinetic parameters of hydrolysis process, 
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which are the maximum specific hydrolysis rate (kh) and half saturation coefficient 
for hydrolysis (KX) were suggested as model parameters that have to be adjusted 
during model calibration procedure (Ciggin, 2011a). The stoichiometric and kinetic 
parameter values used by the task group in the modelling studies reported are listed 
in Table 2.4 for 10 °C and 20 °C. 
Table 2.4 : Typical parameter values at neutral pH. 
Symbol Characterization 
Temperature 
Units 10 °C 20 °C
YH Heterotrophic yield coefficient 0.67 0.67 g cell COD.(g COD)-1 
fp 
Fraction of biomass for 
particulate product 0.08 0.08 - 
μH Maximum specific growth rate for heterotrophicbiomass 6.0 3.0 d
-1 
KS 
Half-saturation coefficient for 
heterotrophicbiomass 20.0 20.0 g COD m
-3 
bH 
Decay coefficient for 
heterotrophicbiomass 0.62 0.20 d
-1 
kh Hydrolysis rate constant 3 3 d-1 
KX Hydrolysis saturation constant 0.03 0.03 g.COD.(gCOD)-1 
ASM1 is basically structured on the assumption that active biomass is converted to a 
combination of particulate residual products and slowly biodegradable substrate, 
through death and lysis as schematically plotted in Figure 2.10. No loss of COD is 
involved and no direct electron acceptor is utilized. The slowly biodegradable 
substrate released is hydrolysed, generating an equivalent amount of readily 
biodegradable COD. Under aerobic conditions, new cells are produced at the expense 
of this COD fraction together with oxygen uptake (Orhon et al, 2009a). 
 
Figure 2.10 : Death regeneration process in ASM1 (Orhon and Artan, 1994). 
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2.6.2 Activated Sludge Model No.3 (ASM3) 
ASM1 was first introduced by Henze et al. (1987) to interpret the carbon oxidation 
based on the assumption that the external substrate is consumed only for biomass 
growth. For this reason, models generally presume that microbial growth is the only 
biochemical mechanism for growth; substrate is directly converted into biomass 
which is subsequently used for endogenous respiration. However, in the last decade 
several researchers observed the phenomenon of storage of carbon sources as 
intracellular polymers that plays a significant role in carbon removal process (van 
Loosdrecht et al, 1997b; Majone et al, 1999). It has been recognized that bacterial 
populations adopt a survival strategy when exposed to feast (presence of external 
substrate) and famine (absence of external substrate) conditions, because of transient 
conditions. For this reason, the Activated Sludge Model No.3 (ASM3) model was 
built on the basis of storage concept of readily biodegradable substrate by IWA Task 
Group (Gujer et al, 1999; Gujer et al, 2000).  
In ASM3, it is hypothesized that all readily biodegradable substrate (SS) is first 
stored as an internal storage product (XSTO), either directly or through preliminary 
hydrolysis, and then growth occurs only on internally storage polymers during the 
famine (unavailability) phase. ASM3 is one of the most referenced models for the 
quantitative analysis of activated sludge processes. The storage yield (YSTO), is one 
of the most important parameters of the simultaneous storage and growth models, 
since it represents the stoichiometric amount of the substrate converted into storage 
products, which are then utilized for growth. The assessment of YSTO is therefore 
crucial for the accurate estimation of the overall electron acceptor utilization and 
sludge production. As the YSTO mainly depends on the carbon source, it is essential 
to evaluate the storage in relation to the type of the produced storage polymers. 
Consequently, the substrate uptake rate and consequently YSTO rely on the external 
carbon source, which determines the type of storage polymers. It was also suggested 
that the storage rate (kSTO) is changing with environmental conditions (Hanada et al, 
2001).As these stoichiometric and kinetic values highly depend on the environmental 
conditions, it is better to evaluate these parameters based on the operating parameters 
of activated sludge systems. The growth environment, namely operating conditions, 
controls the expression of the genetic capabilities of the organisms such as the levels 
of the enzymes, which vary with the growth environment. The type of storage 
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polymer and operating conditions also determine the species of microorganisms 
present in activated sludge systems. 
The ASM3 model represents an alternative process description for heterotrophic 
bacteria. Under transient loading conditions, heterotrophic bacteria can store organic 
matter as polymeric compounds like polyhydroxyalkanoate (PHA) or glycogen 
(GLY). This storage can influence the overall process of activated sludge by 
supplying organic material under starvation conditions. The reaction kinetics and 
stoichiometry of ASM3 simplified for organic carbon removal is given in Table 2.5. 
The mechanisms participating in oxygen utilization are storage, growth, endogenous 
decay and respiration of storage products. 
The net (true) yield of heterotrophic biomass (XH) produced per unit of readily 
biodegradable substrate (SS) removed in ASM3 are found from following equation. 
 (2.4) 
         Table 2.5 : The simplified ASM3 for organic carbon removal under aerobic 
conditions. 
Component SO SS SI XS XI XH XSTO Process rate 
Process   
Hydrolysis   (1 )SIf  SIf -1 
 
  S Hh H
X S H
X Xk X
K X X
   
 
Storage of 
SS 
(1 )STOY   -1 
 
 
 
 STOY . .o SSTO H
o o STO S
S Sk X
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            
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XSTO H
H
Y
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1 /ˆ .
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H H
o o STO STO H
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        
 
Endogenous 
respiration (1 )If    
 
 If -1  . .oH H
o o
Sb X
K S  
Respiration 
of XSTO -1  
 
 
 
 -1 . . STO
o
STO
o o
Sb X
K S  
Parameter O2 COD  COD  Cell COD COD
 
Stoichiometric parameters of ASM3 under aerobic conditions are identified together 
with their units and a typical value in Table 2.6. In relation to removal of all soluble 
compounds, the kinetic expressions of ASM3 rely on switching functions, which are 
2,2,2, . OHOSTOOnet YYY 
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hyperbolic or saturation terms, Monod equations, S/(K+S). Similarly, the switching 
functions are affected for particulate compounds by the ratio of XSTO/XH and XS/XH.  
Table 2.6 : Typical stoichiometric parameters of ASM3. 
Symbol Characterization Value Units 
YSTO Aerobic yield of stored product per SS 0.85 g CODXSTO.(g CODSS) -1 
YH Aerobic yield of heterotrophic biomass 0.63 g CODXH.(g CODXSTO) -1 
fXI 
Production of XI in endogenous 
respiration 0.20 g CODXI.(g CODXBM)
 -1 
ISS,XI SS to COD ratio for XI 0.75 g SS.(g CODXI) -1 
ISS,XS SS to COD ratio for XS 0.75 g SS.(g CODXS) -1 
ISS,BM SS to COD ratio for biomass, XH 0.90 g SS.(g CODXBM) -1 
The units and typical values for kinetic parameters of ASM3 under aerobic 
conditions at 10 ˚C and 20 ˚C are identified in Table 2.7. 
Table 2.7 : Typical values for kinetic parameters of ASM3. 
Symbol Characterization 
Temperature
Units 
10 °C 20 °C 
kh Hydrolysis rate constant 2 3 g CODXS.(g.CODXH)-1.d-1 
KX 
Hydrolysis saturation 
constant 1 1 g.CODXS.(g.CODXH)
-1 
kSTO Storage rate constant 2.5 5 g CODSS.(g.CODXH)-1.d-1 
KS 
Saturation constant for 
substrate SS 
2 2 g CODSS m-3 
KSTO 
Saturation 
constantforXSTO 
1 1 g.CODXSTO.(g.CODXH)-1 
μH Heterotrophic maximum growth rate of XH 1 2 d
-1 
bH 
Aerobic endogenous 
respiration rate of XH 
0.1 0.2 d-1 
bSTO 
Aerobic respiration rate for 
XSTO 
0.1 0.2 d-1 
ASM1 adopted substrate utilization by direct growth, whereas ASM3 suggested 
storage of substrate in the form of internal storage polymers followed by its 
utilization for other biochemical processes (Katipoğlu et al, 2010). The main 
difference between ASM1 and ASM3 is the recognition of the importance of storage 
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polymers in activated sludge processes. At the same time the decay process from 
ASM1 is replaced by an endogenous respiration process. The endogenous respiration 
concept originated from the observation that internal storage materials are used for 
maintenance purposes when the external substrate is depleted (Van Loosdrecht and 
Henze, 1999).  
A major difference for the wastewater characterization between ASM1 and ASM3 is 
that soluble (SS) and particulate (XS) biodegradable components in ASM3 are 
supposed to be differentiated with filtration over 0.45 μm membrane filters, whereas 
a significant fraction of the slowly biodegradable organic substrates (XS) in ASM1 
would be contained in the filtrate of the influent wastewater (Gujer et al, 1999). 
The observation from OUR tests with activated sludge which revealed the fact that 
bacteria will rapidly take-up readily biodegradable COD and store it as internal 
substrate which will further be converted slowly (conversion ofreadily biodegradable 
COD into slowly biodegradable COD). When the acetate (defined substrate) is added 
to the activated sludge the observed OUR suggests the presence of two substrates; 
the OUR associated rapid and slow degradation of substrate can be observed in 
Figure 2.11.  
 
 Figure 2.11 : Differences between ASM1 and ASM3. 
In ASM1 it is reflected as if two substrate are present (SS and XS) while in reality 
only acetate (SS) is dosed. In order to describe the observed OUR by ASM1 in this 
 44 
case, it is necessary to define that the acetate is partly soluble and partly particulate, 
which is not recommended. This deficiency is solved by the introduction of a storage 
compound, XSTO,S in ASM3. It means that substrate is taken up rapidly and stored, 
while growth occurs with the stored substrate. Both models will describe the 
observed OUR, but only ASM3 will describe well the acetate uptake (Henze et al, 
2008). 
2.6.3 Substrate Storage Phenomena 
Storage has been explained as the survival mechanism when microorganism is 
prevented from growing at its maximum rate (Van Looshdrect et al, 1997b). 
Although the substrate is transported into the cell, the biosynthetic growth limitations 
may prevent the consumption of all energy. This leads to an increase in energy 
charge which, in turn, leads to storage of the substrate. In this way, favourable 
growth conditions are established to face against this highly dynamic environment in 
activated sludge processes (Ciggin, 2011a).  
As a result of highly dynamic feeding conditions in activated sludge systems, 
microorganisms are subjected to feast-famine regime. This process is also currently 
known as‘‘aerobic dynamic feeding(ADF)”.These periods were explained as: when 
external carbon source is available only short periods of time, microorganisms 
consume substrate and produce storage polymers in feast period whereas no external 
substrate is found and consumption of stored polymer occurs for growth in famine 
period (Van Loosdrecht et al, 1997b). If there was no external substrate, bacteria 
would undergo long starvation periods. Starvation by substrate for a certain period of 
time can cause a decrease in the amount of intracellular components (RNA and 
enzymes) needed for growth. Following this period of substrate limitation, cells 
faced with an excess of substrate can take it up rapidly. However, the growth rate 
does not increase at a rate that corresponds with the substrate uptake rate. This 
difference is related to the fraction of substrate stored or used for cell maintenance. 
After starvation, storage occurs preferentially instead of cell growth because the 
amount of enzymes required for storage are lower than the enzymes needed for 
growth at maximum rate. During the famine period, the stored substrate is used for 
cell growth and cell maintenance. Operation of a reactor under feast and famine 
conditions can selectively enrich a mixed population with a high storage capacity 
(Reis et al, 2006). Owing to storage ability, microorganisms have a competitive 
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advantage over the other bacteria without the capacity of substrate storage. If bacteria 
can not store the substrate; extra energy is needed for rapid growth in feast period 
(Van Loosdrecht et al, 1997b). Thus, storage process requires significant amount of 
energy for removal of soluble substrate. 
2.6.3.1Polyhydroxyalkanoates (PHAs) 
It is reported that when activated sludge culture is fed with volatile fatty acids 
(VFAs), the storage polymers are Polyhydroxyalkanoates (PHAs) which are 
intracellular energy and carbon storage materials synthesized by numerous 
microorganisms (Lee, 1996). Microbial production of PHA, both under aerobic and 
anaerobic conditions, has gained considerable interest because of the potential 
applications of these polyesters as biodegradable plastics (Brock and Madigan, 
1991). PHAs can be thermoplastically moulded and can be used as new plastics 
which have the advantage over polypropylene and polyethylene of being 
biodegradable. They can be transformed into sheets, fibres and hollow bodies like 
bottles and mugs. Besides being the only linear biodegradable polyester, they are 
also biocompatible with numerous applications in medicine, pharmacy and 
packaging (Steinbüchel and Wiese, 1992). While PHA-based plastic substitutes are 
less flexible than traditional plastics, they are completely biodegradable and leave 
behind no residue. More than 40 different hydroxyalkanoic acids (HAs) have been 
detected as constituents of PHA, but only few homopolyesters besides poly(3-
hydroxybutyrate) (PHB) are available from bacteria (Steinbüchel and Wiese, 1992).  
More recently, recombinant strains for cost-effective PHA production (properties 
include: rapid growth, high cell density, ability to use several inexpensive substrates, 
and simple polymer purification) have been developed by cloning the PHA synthase 
genes from many microorganisms, including Ralstonia eutropha (recently renamed 
as Cupriavidus necator).  
Industrial processes for the production of PHAs as a bioplastic employ generally 
pure cultures such as Ralstonia eutropha, Alcaligenes latus, and Burkholderia 
sacchari (Reis et al., 2006) of natural PHA producers or recombinant bacteria. For 
example, the production of PHA by recombinant Escherichia coli harboring R. 
Eutropha can reach 80–90% of the cell dry weight (Reis et al, 2006). However, the 
production costs are still too high for PHAs to become a competitive commodity 
plastic (Dias et al, 2006). Production costs could potentially be reduced by using 
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open undefined mixed culture processes for the production of PHA and waste 
streams rather than pure chemicals as substrates (Kleerebezem et al, 2009). With the 
aim of commercializing PHA, a great deal of effort has been devoted for reducing the 
production cost by using activated sludge as a mixed culture and a renewable 
resource (Satoh et al, 1999; Kumar et al, 2004; Yan et al, 2006; Cai et al, 2009).  
In general, mixed cultures are microbial populations of unknown composition, which 
are able to perform specific intracellular and extracellular reactions, and are selected 
by the operational conditions imposed on the biological system. Mixed cultures 
selected for PHA production can have a high intracellular storage capacity due to 
operational conditions that limit their primary metabolism. PHA synthesis assume 
that accumulation occurs when growth is limited by external factors such as a lack of 
nutrients (for example, phosphorus or nitrogen) or internal factors such as an 
insufficient amount of RNA or enzymes required for growth (Reis et al, 2006). 
Activated sludge is known to accumulate up to 65% PHA per cell dry weight. There 
are currently many possibilities of industrial and agricultural wastes that could be 
directed to the production of PHA on the basis of open mixed microbial systems 
(Lemos et al., 2008).  
A promising approach for producing PHAs with mixed cultures is the use of a two-
step process. In the first step a PHA producing culture is enriched using alternating 
presence and absence of the carbon source (feast and famine periods) as a selective 
pressure, hereby making use of the ecological role of PHAs as a storage polymer. 
This feast - famine regime can be implemented using a sequencing batch reactor 
(SBR). In the second step the culture enriched in the first step is subjected to 
continuous presence of the carbon source, usually under growth limiting conditions, 
in order to maximize the cellular PHA content (fed-batch reactor) (Kleerebezem et 
al,  2009).  
In other words, the strategy for the enrichment of heterotrophic organisms in the 
sludge is a critical factor for the process productivity. The feast and famine feeding 
regimen was shown to be an effective strategy for selecting the heterotrophic 
organisms with high PHA storage capacity. The results of many studies demonstrate 
undeniably that mixed cultures submitted to the feast and famine regimen have high 
PHA storage capacity, high PHA yields, and high specific PHA productivity (Reis et 
al, 2006). 
 47 
The type of PHA components produced depends on the composition of substrate. 
Well known monomeric units of PHA in activated sludge are poly-β-
hydroxybutyrate (PHB) and poly-β-hydroxyvalerate (PHV). In addition to these two 
main polymers, the production of other PHA components such as 3-hydroxy-2-
methylbutyrate (3H2MB) and 3-hydroxy-2-methylvalerate (3H2MV) may also be 
significant (Satoh et al, 1992). More than 40 different hydroxyalkanoic acids (HAs) 
have been detected as constituents of PHA, but only few homopolyesters besides 
poly (3-hydroxybutyrate) (PHB) are available from bacteria (Steinbüchel and Wiese, 
1992). 
2.6.3.2 Polyhydroxybutyrate (PHB) 
The most common forms of PHA accumulated by microorganisms are 
polyhydroxybutyrate (PHB) which is most well-known storage polymer associated 
with simple external substrates such as volatile fatty acids and especially acetate 
(Satoh et al, 1992; Dionisi et al, 2001; Karahan-Gül et al, 2002a).  
In 1926, Lemoigne was the first to describe PHB as cell internal component. It would 
take until 1960 before a renewed interest was created because of the presumed 
metabolic significance of PHBs. The storage polymer was particularly encountered 
under certain growth conditions such as limiting nutrient conditions (low N/COD 
ratio) (Braunegg et al, 1978; Baetens, 2001). PHB is an energy and carbon source 
derived from the fermentation processes of several kinds of bacteria, such as Bacillus 
megaterium and Ralstonia eutrophus. In addition, PHB is water insoluble and 
relatively resistant to hydrolytic degradation. This differentiates PHB from most 
other currently available biodegradable plastics, which are either water soluble or 
moisture sensitive. This compound is also good oxygen permeability and soluble in 
chloroform and other chlorinated hydrocarbons (Baetens, 2001). PHB is present as 
granules enclosed by a membrane in the cytoplasm of the cells. The granules of PHB 
have typical diameters of 0.2 to 0.5 µm. Figure 2.12 depicts a general structure of 
PHAs. 
The regulation of PHB synthesis is controlled at enzymatic level and mainly depends 
on the intracellular concentration of acetyl-CoA and free coenzyme A (CoA). The 
production of storage polymers is thought as serving a NADH overflow mechanism 
to control the redox state of heterotrophic cells during unbalanced growth conditions 
(Van Niel et al, 1995).  
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Figure 2.12 : General structure of PHA (R: methyl: PHB and R: ethyl: PHV). 
As illustrated in Figure 2.13, after bacteria take up acetate into cell, it is converted to 
acetyl-CoA and the produced acetyl-CoA is primarily used in the tricarboxylic acid 
(TCA) cycle to produce ATP, NADH2 and to form biomass. When growth conditions 
are unbalanced, acetyl-CoA cannot enter TCA cycle to obtain energy for cells due to 
high concentrations of NADH. High concentrations of NADH inhibit citrate 
synthase, one of the key enzymes of TCA cycle, leading to an increase in the level of 
acetyl-CoA. For PHB synthesis, two molecules of acetyl-CoA are condensed to form 
acetoacetyl-CoA and release a CoA. The enzyme 3-ketothiolase catalyzes this 
condensation reaction. The increase in the concentration of acetyl-CoA drives the 
equilibrium reaction of 3- ketothiolase into the direction of PHB synthesis. The 
acetoacetyl-CoA is reduced to (R)-3-hydroxybutyryl-CoA. This reaction is catalyzed 
by NADPH-dependent acetoacetyl-CoA reductase and (R)-3-hydroxybutyryl-CoA 
molecules synthesize PHB with the release of free CoA (Ciggin, 2011a). 
Subsequently, PHB is accumulated in order to keep the concentration of 
intermediates at a balanced level in cells. It is likely that when the ratio acetyl-
CoA/CoA is high, the cells will respond with the production of more anabolic 
enzymes, i.e. increase their growth rate. If the period of excess external substrate 
availability is long enough, the specific growth rate of the biomass will increase to its 
maximum and the PHB synthesis rate will slow down (Ciggin,2011a). 
Depolymerization of PHB appears to be inhibited in the presence of a soluble 
substrate favouring rapid growth. However, certain observations seem to indicate 
that degradation of PHB occurs at the same time as its synthesis. When PHB is used 
by biomass while no external substrate is available, PHB is converted to D(-)-3-
hydroxybutyrate by PHB depolymerise and then produced D(-)-3-hydroxybutyrate is 
converted to acetoacetate by D(-)-3-hydroxybutyrate dehydrogenase. Finally, 
acetoacetyl-CoA is formed by acetoacetyl-CoA synthetase. Metabolic pathway 
involved in the synthesis and degradation of PHB require energy and reducing 
(CH2)nC
H
O 
O 
n = 102 - 104 
C 
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power. Although, the knowledge of the PHB degradation pathway is very limited, it 
is accepted that one of the steps in the biochemical pathway of PHB degradation 
must be the rate limiting (Ciggin, 2011a). 
 
      Figure 2.13 : PHB production pathways in feast/famine conditions (adapted from 
Salehizadeh and Van Loosdrecht, 2004). 
2.6.4 Metabolic models 
A metabolic model is based on the principle that the metabolism of organism is 
composed of a limited number of metabolic pathways which results in more or less 
constant energy requirement and ultimately constant stoichiometry (Roels, 1983). 
Metabolic pathways are described with internal reactions that are combined with 
reaction stoichiometry and degree of reduction balances to derive the linear equation 
for description of involved metabolism. 
A metabolic model was proposed that acetate is aerobically stored as PHB under 
dynamic conditions by van Aalst-van Leeuwen et al. (1997a). This metabolic model 
reduces the number of unknown parameters and describes the observed kinetics of 
PHB formation and consumption by selected microorganism.  
The substrate uptake rate will be larger than required for growth when carbon source 
is given periodically. It was observed that the fast uptake of substrate results in the 
formation of NADH2 which is consumed by oxidative phosphorylation and leading 
to ATP formation. If the energy needed for growth is limited, ATP will accumulate 
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which is lead to accumulation of NADH2. This explains that the production of a 
more reduced storage polymer PHB (requires NADH2) is more likely to be compared 
with the production of glycogen (leads NADH2 formation). 
Van Aalst-van Leeuwen et al. (1997a) used acetate limited continuous culture of 
Paracoccus pantotrophus sp. in order to observe the metabolism of a microorganisms 
capable of producing and consuming which was described by seven internal reaction 
(Figure 2.14). Bacterial biomass is assumed to consist of two compartments: (i) an 
active biomass compartment and (ii) a poly(β)-hydroxybutyrate compartment. The 
active biomass is capable of reproduction and growth; the PHB is used as storage for 
carbon and energy. The fraction of PHB in the total biomass is called fPHB. The 
fraction of active biomass in the total biomass is (1-fPHB). 
 
 Figure 2.14 : Schematic representation of the metabolism of an organism capable of 
forming and consuming PHB (van Aalst-van Leeuwen et al, 1997a). 
 Synthesisof Acetyl-CoA from Acetate, (r1): Acetate is taken up by the cell 
by means of active transport and activated to form Acetyl-Pi, then this is 
further converted into acetyl-CoA. 
 Synthesis of biomass monomers from Acetyl-CoA, (r2): Anabolism, the 
synthesis of active biomass, involves two distinct types. First the biomass 
monomers are synthesized. 
 Polymerization of biomass precursors and maintenance, (r3): the biomass 
precursors are polymerized into active biomass.  
 Carbon source catabolism, (r4) 
 Oxidative phosphorylation, (r5): In oxidative phosphorylation, ATP is 
produced from NADH2. 
Acetyl-CoA Acetate Monomers Biomass 
r1 r2 r3 
r4 
r5 
r6 
PHB 
r7
NADH2 
ATP 
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 Synthesis of the storage product PHB from Acetyl-CoA, (r6): The 
substrate is used not only for synthesis of biomass and for catabolism but also 
for the synthesis of PHB. 
 Synthesis of Acetyl-CoA from PHB, (r7): In the absence of acetate, the 
microorganisms utilize the intracellular accumulated PHB as carbon and 
energy source. The storage polymer is hydrolyzed and converted into Acetyl-
CoA. 
The metabolic model results in two equations describing the conversion processes for 
feast and famine phases. For the feast period, the linear equation describing acetate -
uptake, biomass growth, PHB production and maintenance is defined as below 
Equation (2.5). 
XSP
SP
X
SX
S CmrY
r
Y
r  maxmax 11)(  (2.5)  
As similar, PHB consumption, biomass growth, and maintenance are expressed with 
the following equation for the famine period Equation (2.6): 
XPX
PX
P CmrY
r  max1)(  (2.6) 
where, 
32.413.4
24max

 

SXY  (2.7) 


5.4
24max SPY  (2.8) 
32.413.4
5.05.4max

 

PXY  (2.9) 
12  
ATP
S
mm  (2.10) 
5.05.4  
ATP
P
mm  (2.11) 
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The linear equations contain two unknown parameters namely, the ratio between -
ATP produced and electrons transferred from NADH2 to an electron acceptor (δ) and 
the ATP consumption due to maintenance processes (mATP). Substition of rX=μCX, 
rS=qS.CX, rP=qP.CX followed by division by biomass concentration, CX gives the 
following Equation (2.12): 
SP
SPSX
S mqYY
q  maxmax 11)(   (2.12) 
From earlier experiments (Pot, 1996), it was observed that maximum yield of 
biomass on acetate, YSXmax= 0.45 [C-mol/C-mol] and maintenance coefficient for 
growth on acetate mS = 0.038 [C-mol/C-mol.h]. The P/O ratio, δ= 1.84 [mol 
ATP/mol NADH2] and the ATP maintenance coefficient, mATP = 0.102 [mol ATP/C-
mol.h] were calculated by using the related equations and above values, also these 
parameters are considered to be constant within the experimental range. Maximum 
yield of PHB on acetate, YSPmax = 0.648 [C-mol/C-mol] was found by using the 
equation 3.4. Substituting these yield coefficients in Equation (2.12) gives Equation 
(2.13): 
0.038l.544q.2.22  qs- P    (2.13) 
From the carbon balance and the degree of reduction balance relations for the 
specific carbon dioxide production rate (qC) and for the specific oxygen consumption 
rate (qO) can be derived as a function of μ and qPEquation (2.14) and (2.15): 
0.0380.544q1.22  q--)(-q q PPS C    (2.14) 
0.0380.419q1.188  )(-q PO    (2.15) 
Stoichiometry of the kinetic model for the PHB production can be based upon 
Equations (2.13- 2.15). Maximum yield of biomass on PHB, YPXmax = 0.653 [C-
mol/C-mol] and maintenance coefficient for growth on PHB, mP = 0.0131 [C-mol/C-
mol.h] were calculated for the famine phase. Below equations were derived by using 
these values: 
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P
PX
P mY
q  max1)(  (2.16) 
0.01311.532 q- P    (2.17) 
0.01310.532 q  C    (2.18) 
0.0147 0.693  )(-qO    (2.19) 
Stoichiometry of the kinetic model for the PHB consumption can be based upon 
Equations (2.16 -2.19). It was observed from experimental and modeling results that, 
the substrate uptake rate reaches its maximum value immediately after the pulse 
addition of carbon source. However, the growth rate is only influenced by maximal 
growth rate, and slowly decreases during growth on PHB presumably being related 
to the reduction in PHB amount (van Aalst- van Leeuwen et al, 1997a). According to 
the standard theory, the substrate uptake rate in a chemostat is found by the 
multiplication of the maximum uptake rate and Monod factor for the substrate 
relationship. This is an evidence for that the organisms will induce a maximal level 
of substrate uptake enzymes, while the enzyme system for cell growth will not be 
completely induced. So, even though the cells are cultivated close to growth rate of 
zero, the maximum substrate uptake activity will be maintained. Since the conditions 
are firmly different from a chemostat in wastewater treatment processes under 
dynamic conditions, it can be discussed that under such conditions microorganisms 
that have a fully induced substrate uptake system, accumulate more substrate and out 
compete organisms that do have lower substrate uptake rates. 
The maximum substrate uptake rate of an organism is generally independent of the, 
real growth rate of that organism (Roels, 1983). In the model of van Aalst-van 
Leeuwen et al. (1997a), it was proposed that PHB is generally used as a buffer for 
the substrate taken up but not directly used for growth. The storage polymers can 
play a significant role in microbial growth under unbalanced conditions (van 
Loosdrecht et al, 1997a).  
To evaluate storage mechanism, Krishna and Van Loosdrecht (1999) have observed 
that ASM3 failed to model two significant experimental observations: (i) the 
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discontinuity in the growth rate of biomass observed experimentally in feast and 
famine phases and (ii) it required prediction of higher levels of internal storage 
polymers than measured to fit the oxygen consumption during feast and famine 
phases. Guisasola et al. (2004), moreover, showed that for batch OUR data, ASM3 
approach also causes severe practical identification problems that resulted in 
unrealistic and nonmechanistic parameter estimates which is the traditional way in 
model calibration. The major reason of this failure was the experimentally observed 
fact that storage and growth occur simultaneously during the feast phase as opposed 
to the assumption of ASM3 that only storage occurs during the feast phase (Krishna 
and Van Loosdrecht, 1999). 
The experiments carried out in activated sludge systems, operating under dynamic 
conditions indicate that although the storage of internal polymers is usually the main 
mechanism for the removal of readily biodegradable carbon sources, bacteria can 
grow on both external and internal substrate under dynamic conditions (Ciggin, 
2011a). It has been reported that bacteria use external substrate preferentially for cell 
growth (i.e. to optimize the growth rate) or for storage processes (i.e. to optimize the 
substrate uptake rate). This fact led to the formulation of the first simultaneous 
storage and growth model in order to interpret the experimental data better by 
Krishna and Van Loosdrecht (1999). From a mechanistic modelling point of view, it 
becomes clear that ASM3 should be extended to account for simultaneous storage 
and growth.  
Activated Sludge Model for Growth and Storage (ASMG) had six components, 
namely, readily biodegradable substrate (in this study HAc was used as substrate), 
SS, organics stored by heterotrophs (in this study storage is equivalent to PHB), XTSO, 
heterotrophic biomass, XH, inert particulate organics, XI, total suspended solids, XTS 
and finally, dissolved oxygen, SO. Accordingly, it incorporated five biochemical 
processes: aerobic storage of COD; aerobic growth on PHB; aerobic endogenous 
respiration; aerobic respiration of PHB and aerobic growth on acetate (Krishna and 
Van Loosdrecht, 1999). A matrix representation of the metabolic model for aerobic 
conditions, including rate expressions and model coefficients of all relevant 
processes is given in Table 2.8. 
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Table 2.8 : Matrix representation of simplified ASM3 (Krishna and van Loosdrecht 1999). 
Component SO SS XI XH XSTO XTS Process rate 
Process       
Aerobic storage 
of COD  
(PHB storage) 
 STOY 1  -1    YSTO 
 
. .SSTO H
S S
Sk X
K S  
Aerobic growth 
on PHB 2
21
H
H
Y
Y     1 
2
1
HY
  
 
2
/. . .
/
S STO H
H H
S S STO STO H
S X X X
K S K X X
    
Aerobic 
endogenous 
respiration 
 If 1    fI -1  
 
.H Hb X  
Aerobic 
respiration of 
PHB 
-1      
 
.STO Hb X  
Aerobic growth 
on acetate 1
11
H
H
Y
Y  
1
1
HY
   1  
 
1. .SH H
S S
S X
K S
   
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For simultaneous storage and growth, three yield factors have been introduced that 
are the yield for growth of biomass on substrate (YSX), the yield of storage on 
substrate (YSP) and the yield of growth on the stored substrate (YPX). If there is no 
simultaneous storage and growth, it is not necessary to define the yield for growth on 
external substrate. The schematic comparison of the ASM3 and metabolic model 
involving simultaneous growth and storage is illustrated in Figure 2.15. 
 
Figure 2.15 : Metabolic route of biomass (a) in ASM3 and (b) metabolic model    
proposed Krishna and Van Loosdrecht (1999). 
In addition to Krishna and Van Loosdrecht (1999), several models have been 
proposed to improve the mechanistic modelling of simultaneous storage and growth 
processes in activated sludge systems. Orhon et al. (2009b), also evaluated that 
modeling of peptone biodegradation with simultaneous PHA storage was basically 
constructed on the same modified ASM1 template utilized in the earlier part of the 
experimental evaluation. The adopted model structure (growth-storage model) 
included a new model component reflecting the concentration of the storage 
products, XPHA and two new processes, namely storage and growth on stored PHA, 
as given in a matrix format in Table 2.9. The storage process was conventionally 
defined in terms of a similar Monod-type of an expression where kSTO denotes the 
maximum storage rate. In this study, peptone was selected as carbon source because 
it is very similar to domestic sewage in terms of biodegradation characteristics. Also, 
it contains a similar balance between readily biodegradable COD and slowly 
biodegradable COD fraction. The kinetic and stoichiometric parameters of other 
related studies are given in Table 2.10. 
 
 
YSTO YH 
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Table 2.9 : Matrix representation of the model structure for simultaneous growth and storage (Orhon et al, 2009b). 
Component 
SO2 SS SH1 SH2 XH XSTO XP Process rate
 Process 
Hydrolysis of SH1  1 -1     
1
1 /. .
/
H
H H
h H
X H
S Xk X
K S X  
Hydrolysis of SH2  1  -1    
2
2 /. .
/
H
H H
hx H
XX H
S Xk X
K S X  
Storage of PHA 
 STOY 1
 
-1    YSTO  . .
S
STO H
S S
Sk X
K S  
Growth of XH 
1 H
H
Y
Y
  1
HY
    1   . .SH H
S S
S X
K S
   
Growth on PHA 
1 H
H
Y
Y
     1 1
HY
   .STO STOX  
Decay of XH -(1-fp)    -1  fp .H Hb X
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Table 2.10 : Kinetic and stoichiometric parameters of ASM3 and modified ASM3. 
Parameters Insel et al, 2012 
Cokgor 
et. al, 
2011 
Ural, A., 
2011 
Ciggin, 
A.S., 
2011a 
Orhon 
et al, 
2009b 
Cokgor et. 
al, 2008 
Karahan 
et al, 
2008 
Insel  et 
al, 2007 
Karahan 
et al, 
2006 
Karahan-Gül       
et al, 2003 
Krishna and van 
Loosdrecht, 1999 
Model Type  Modified ASM3 
Adopted 
model 
Modified 
ASM3 
Modified 
ASM3 ASM3 ASM3 
Modified 
ASM3 
Proposed 
model 
Modified 
ASM3 ASM3 
Modified 
ASM3 ASM3 
Modified 
ASM3 
SRT(day) 10 2 10 10 8 2 10 10 - 5 5 20 2.5 
Carbon Source Acetate Peptone Acetate Acetate Peptone Synthetic wastewater 
Acetic 
acid Glucose 
Soluble 
starch Acetate Acetate 
μHmax(1/day) 3.9 6.8 4.1 3.5 1.5 2.5 6.1 3.2 3 15.1 3 - 4 - 2 
μSTO(1/day) 4.7 2.2 1.25 3.5 1.5 2.0 1.10 - 5 - 4 3 & 1.8 3 - 3.5 
KS (mg COD/L) 6 25 4.0 6.0 5 10 2.3 40 5 16 20 4 3 0.1 0.1 
KSTO(mg 
COD/L) 1 5 0.41 0.3 0.45 0.5 - 0.002 0.5  0.4 1 0.4 1 1 
bH (1/day) 0.22 0.22 0.20 0.2 0.20 0.20 0.20 0.20 0.10 0.15 0.10 0.24 0.24 0.2 0.2 
bSTO (1/day) - - - - 0.10 0.10 - 0.20 0.05  0.05 0.24 0.24 0.2 0.4 
kSTO (1/day) 5.7 6.3 0.90 5.7 8.0 6.5 0.45 - 15 1.4 25 16 14 10 10 
YH (mg COD/       
mg COD) 
0.66 0.66 0.60 0.66 0.68 0.68 0.60 0.67 - 0.47 0.79 - 0.65 - - 
YSTO (mg COD/    
mg COD) 0.80 0.80 0.80 0.80 0.85 0.85 0.80 0.78 0.76 0.90 0.91 0.80 0.80 - - 
kh (1/day) - - 4.34 - - - 5.95 - - - 30 - - - - 
KX (mg COD/       
mg COD) - - 0.03 - - - 0.05 - - - 0.15 - - - - 
fES 0.05 0.05 0.05 0.05 - - 0.05 0.05 - 0.05 0.05 0.05 0.05 - - 
fEX 0.15 0.15 0.15 0.15 - - 0.15 0.15 - 0.15 0.10 0.15 0.15 - - 
SBR cycles 1 1 1 1 6 6 1 1 6 1 6 1 1 6 6 
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2.6.5 Effects of SRT on storage kinetics 
As the average growth rate of the biomass is mainly controlled by the sludge age 
(SRT), SRT has been used for the determination of the mean microbial life-time, and 
hence microbial population in activated sludge systems (Frigon, 2006). Although, 
ASM3 suggested the default value of storage yield as 0.85 g COD/g COD, extensive 
experimental studies showed that storage yield ranges from 0.38 to 0.79 
gCOD/gCOD according to different SRT. Storage yield values for different 
substrates and related sludge ages found in several studies are given in Table 2.11.As 
seen from the Table 2.11, different yield values were reported by different authors 
for the same substrates.  
Table 2.11 : Experimentally found storage yield values for different SRT. 
Reference  
Growth conditions of  
activated sludge Carbon source 
YSTO 
(g COD/
g COD) SRT (days) 
Feed composition 
(Ratio, COD based) 
Beun et 
al.(2000) 3.8 Acetate Acetate 0.69 
Beun et al. 
(2002) 2-20 Acetate Acetate 0.68 
Carta et 
al.(2001)  6.1 Acetate+glucose (1:1) Acetate+glucose 0.6-07 
Dionisi et 
al.(2004) 1 Acetate + Lactate + propionate (2:2:1) 
Acetate 0.49 
Propionate 0.38 
Lactate 0.32 
Goel et al. 
(1998) 10 
Acetate + Glucose + 
Peptone + Yeast Extract 
(2:1:1:1) 
Glucose 0.68 
Acetate 0.45 
Starch 0.36 
Krishna and 
Van  
Loosdrecht 
(1999) 
2.5 Acetate Acetate 0.73 
Martins et al. 
(2003) 7-10 Acetate Acetate 0.47-0.59
The storage yields directly calculated from the fraction of removal substrate to 
produced PHB (qP/-qS), which is recovered as storage compound. The faster 
substrate uptake rate (-qS) has been usually interpreted as indirect evidence of more 
relevant presence of a storage response in activated sludge process (Van Loosdrecht 
et al, 1997a). Briefly, experiments showed that while substrate uptake rate (-qS) 
decreased linearly, storage compound production rate (qP) linearly increased in the 
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feast period when extra cellular substrate is available. The fraction of substrate 
removed to storage polymer produced (qP/-qS) is used as an indication of which 
fraction of the substrate is stored. The substrate uptake rate is limited by the substrate 
concentration. Although a linear relation exists between substrate uptake and 
biomass growth in the systems where only biomass growth is observed, more 
complicated relations are present between the substrate uptake rate, biomass growth 
and PHB production. 
Studies on the storage phenomenon with pure cultures at low SRT (i.e. high growth 
rate) showed that storage is dependent on the growth rate of the culture (Van Aalst-
van Leeuwen et al, 1997a). In other words, the accumulation rate of storage products 
was linearly correlated to the difference between the maximum substrate uptake rate 
and the substrate uptake rate required for growth. When the culture is operated at a 
growth rate close to its maximum substrate uptake rate, storage is observed to be 
negligible. In this range, storage rate changes slightly with SRT while growth rate is 
strongly affected by variation of SRT (Van Loosdrecht and Heijnen, 2002). 
The slower substrate uptake rate and PHA production rate have been observed in the 
SBR fed with acetate at SRT of 1 day then the SBR operated at SRT of 10 days 
although high organic loading was applied at low SRT (Lemos et al, 2008). The 
authors have concluded that the biomass was dominated by species which have high 
specific growth rates at low SRTs, as the growth yield was higher despite of lower 
uptake rates in low SRT. According to Beun et al. (2002); the ratio qP/-qS has a 
constant value for dynamically fed systems operated at a sludge ageSRT>2d. This 
value is 0.6 Cmol/Cmol under aerobic conditions. 
Beun et al. (2000) showed that using the PHB metabolism and adjusting the substrate 
uptake rate enable the bacteria to balance their growth rate under dynamic substrate 
supply and effectively compete for substrate. If acetate is present in excess (feast 
period), it is taken up with the maximal specific acetate uptake rate, which is 
dependent on the SRT. At the same time, PHB is produced with a constant rate. 66% 
to almost 100% of the acetate consumed in steady state systems growing under non-
growth-limiting conditions is used for PHB synthesis processes. This percentage 
increases with increasing SRT. The remainder of the acetate consumed is used for 
growth and maintenance processes. The difference in specific growth rate between 
the feast and famine period decreases with increasing SRT. 
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Dircks et al. (2001) presented that PHB formation is found to be the dominant 
process in heterotrophic conversion of acetate in activated sludge under aerobic 
conditions and yield of PHB on acetate was found around 0.67 COD/COD. 
According to this study, the PHB degradation pattern found in this study is 
dependent on the amount of PHB present in the cells at the end of the feast period. 
The significant part of the total potential growth (90%) is found to occur in the 
famine period on stored PHB. The sludge with SRT of 4 d is found to degrade PHB 
faster than sludge of higher SRTs at high fractions of PHB. 
Van Aalst-van Leeuwen et al. (1997b) observed that faster growing organisms 
accumulated less PHB. In addition to this observation, Majone et al. (2007) showed 
that the overall transient response (i.e. maximum specific substrate removal rate) 
increased as SRT decreased in their pure culture study. Same statement has been 
made by Van Loosdrecht and Heijnen (2002) that the shorter the SRT, the higher the 
growth rate and the less substrate converted into storage polymers. Ciggin et al. 
(2011c) also determined that low sludge age did not alter simultaneous storage and 
utilization for direct growth but it slightly favoured direct utilization due to faster 
growing biomass. 
Alternatively, it was found that activated sludge with an SRT of 3 days had better 
PHA production capability than sludge with an SRT of 10 days (Chua et al, 2003). 
This observation was explained with the selection of microbial community having 
higher PHA production capacity at shorter SRTs than longer SRTs.  
In addition, in the mixed culture, specific PHB production rate in the feast period 
was determined to be almost constant for different SRTs. Higher substrate uptake 
rate was observed in the culture acclimated at the SRT of 3.8 days, than the culture 
acclimated at the SRT of 9.5 and 19.1 days, which were essentially the same (Beun 
et al, 2000).  
Storage yields for glycogen storage from glucose has been founded as 0.96 g COD/g 
COD (Chudoba et al, 1985) and accepted as 0.9 g COD/g COD (Goel et al, 1999). 
This difference in the storage yield of two type of substrate is explained that the 
formation of glycogen from glucose requires less energy than the PHB formation 
from acetate. While storage products are producing at a constant rate in the 
beginning, the rate of storage decreases due to reaching maximum storage capacity in 
time. This causes the overall and observed storage yields to vary over time on the 
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F/M ratio of the experiment. On the other hand, it was observed that F/M ratios did 
not affected the storage yields that were reported as 0.78 g COD/g COD for acetate 
and 0.87 g COD/g COD for glucose (Karahan-Gül et al, 2002a). 
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3.  MATERIALS AND METHODS 
Main aim of this study is to investigate acute and chronic inhibition effects of 
sulfamethoxazole on the biodegradation of acetate under aerobic conditions at low 
sludge age. Sulfamethoxazole (SMX) was chosen as model antibiotic to determine 
the effects of antibiotics on the aerobic activated sludge systems and the removal 
mechanism of the selected substrate at low sludge age. For this purpose, a control 
reactor operated in fill and draw mode was used for the acclimation of activated 
sludge to aimed conditions. Carbon source was added to system once a day and 
biomass was acclimated to pulse feeding pattern in the aerobic batch reactor. The 
control reactor was fed with acetate as a sole carbon source and operated at steady 
state conditions. Aftersteady state conditions were established in control reactor, 
activated sludge culture was taken to perform respirometric tests for acetate removal 
mechanism and acute and chronic effects of antibiotic substance. 
3.1 Reactor Setup 
Experimental study was started up with the set-up of the control reactor. A 
laboratory-scale fill and draw reactor, namely “control reactor” with a net volume of 
4 L was inoculated with activated sludge taken from the acetate acclimated biomass 
used in another study. The control reactor was operated at a sludge ageof 2 days with 
the initial carbon source concentration of approximately 400 mg COD/L (Figure 3.1). 
Acetate representing readily biodegradable substrate was chosen as sole carbon 
source, pH was kept in the range of 6.0 to 8.0, suitable for biological activity and the 
temperature was maintained at 20 ± 1◦C during the operation of reactor. During each 
daily feeding period, reactor was settled for 1 h (ts) and decanted until 2 L (V0). 
Aeration was continuously provided and the oxygen concentration in the reactor was 
kept above 2 mg/L to maintain aerobic conditions. An magnetic stirrer was also 
provided with the reactor in order to mix the contents uniformly. Reactor was 
operated until it reached steady state conditions, which was monitored by suspended 
solids (SS), volatile suspended solids (VSS) and COD measurements. After the 
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control reactor reached at steady state conditions; the acclimated biomass was used 
for respirometric experiments. At steady state, biomass concentration of the reactor 
was stabilized approximately 360 mg VSS/L. 
 
Figure 3.1 : A laboratory-scale control reactor. 
The substrate feed was prepared by diluting a stock solution of sodium acetate 
trihydrate (CH3COONa) in distilled water. The nutrient requirements of the activated 
sludge were supplied with the addition of macro and micro nutrient solutions, namely 
Solution A and Solution B (O’Connor, 1972). The nutrients were supplied for the 
nutritional needs of the cells and to provide enough buffer capacity to the reactor so 
that pH is kept around 7.0. In the reactor, amount of Solution A and B were adjusted 
to supply 10 mL of solution for 1000 mgCOD/L of carbon source (O’Connor, 1972). 
The composition of these solutions is given in Table 3.1.  
3.2 Experimental procedure 
The main idea of respirometric analysis is to measure the change in the respiration 
capacities of activated sludge. Oxygen uptake rate (OUR) profiles should be 
comprehended for the evaluation of substrate removal mechanisms. OUR isalso now 
prescribed as a standard procedure for inhibition assessment (ISO, 2007). It is 
successfully used for the evaluation of the inhibitory impact induced by various 
organic compounds including antibiotics (Karahan et al, 2010). 
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Table 3.1 : Composition of solution acetate, A and B. 
Solution Component Amount of Component (g/L) 
Acetate CH3COONa 95 
Solution A 
NH4Cl 120 
KH2PO4 160 
K2HPO4 320 
Solution B 
MgSO4.7H2O 15 
CaCl2.2H2O 2.65 
FeSO4.7H2O 0.5 
ZnSO4.7H2O 0.5 
MnSO4.H2O 0.41 
Therefore, the OUR experiments were conducted in a respirometer during typical 
batch tests (Orhon et al., 2002).Acetate was added on the biomass to have the same 
S0/X0 ratio with the control reactor and oxygen uptake rate was monitored for the 
assessment of substrate biodegradation behaviour. In the respirometric tests, the 
initial acetate concentration was kept approximately200 mg COD/L, because of this 
both VSS and substrate concentrations were diluted by 1/2 ratio. The obtained OUR 
profile was considered as control in order to evaluate the effects of antibiotic 
substance. In other words, control analysis without antibiotic addition was conducted 
before inhibition analysis for each experiment. The OUR profiles obtained in this 
part of study was used for the experimental assessment of individual stoichiometric 
and kinetics coefficients.  
In this study, OUR measurements were performed with an Applitek RA-Combo-
1000 (Applitek Co., Nazareth, Belgium) continuous respirometer with PC connection 
(Figure 3.2). During each analysis, 1.04 g Allyl Thio Urea (ATU) (Formula 2533TM, 
Hach Company) was added to the OUR reactors as a nitrification inhibitor to prevent 
any possible interference induced by nitrification. The respirometer used in the 
experiments involved a continuous flow-through measurement using the DO 
concentration in the liquid phase to calculate the respiration rate of the activated 
sludge (Spanjers et al, 1996). In principle, the activated sludge was continuously 
transferred to the respirometer with a peristaltic pump. After passing through the 
respiration vessel (0.75 L), where the dissolved oxygen at the inlet and outlet were 
measured by a single DO probe, the sample returned to the OUR reactor. Hereby the 
activated sludge was continuously recirculated. Due to the use of a single DO-
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electrode the measuring frequency was limited by the response rate of the DO-
electrode (Spanjers et al, 1996). The OUR reactor was continuously aerated and 
samples were taken for COD, PHA and antibiotic analyses until the endogenous 
decay was observed after the depletion of carbon source. At steady state, biomass 
concentration of all respirometric experiments was stabilized same ratio control 
reactor at the steady state conditions. In all respirometric experiments, nine samples 
were taken with respect to time till the end of the experiment. Time durations and 
monitored data for experimental runs were given in Table 3.2. 
 
Figure 3.2 : Applitek RA-Combo-1000 continuous respirometer. 
Table 3.2 : Monitored data for experimental runs. 
Time pH SS/VSS COD filtered 
SMX 
filtered PHA 
-30 min x x x x x 
 20 min   x x x 
 40 min   x x x 
 60 min   x x x 
 80 min   x x x 
 100 min   x x x 
 140 min   x x x 
 200 min   x x x 
  24 h   x x x 
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Additional respirometric experiments were conducted on the activated sludge to 
determine acute and chronic effects of antibiotics on the activated sludge system. 
These respirometric tests were started with the approximately same loading ratio 
(S0/X0) with control reactor. After observation of the endogenous decay level in 
terms of straight line, the antibiotic was added to OUR reactor. The antibiotic was 
given to system with different pulse feedings of 25 mg/L, 50 mg/L, 100 mg/L and 
200 mg/L of SMX concentrations to evaluate the acute effects on the carbon removal 
performance. All experiments with antibiotic were conducted in duplicate. The 
summary of control and acute experiments were shown in Table 3.3. 
Although acute effects were characterized by sudden exposure to the substance, 
chronic effects are characterized by prolonged exposures over many times. To 
understand chronic effects of antibiotic substance to activated sludge systems; 12 L 
chronic reactor was set using the seed sludge taken from the control reactor (Figure 
3.3). For understanding the chronic effects, the experimental observation of the study 
involved a period of 18 days after reaching steady state conditions. All chronic 
experiments were done with the same antibiotic concentration (50 mg/L SMX). The 
chronic experiments were given detailed in Table 3.4. Using respirometric studies, 
the chronic effects of SMX on the activated sludge culture was determined by the 
change of the OUR profile in time. In addition, the OUR reactor wrapped in 
aluminum foil to prevent possible photodegradation of sulfamethoxazole in the all 
acute and chronic experiments. 
Table 3.3 : Outline of control and acute experiments at a sludge age of 2 days. 
SUBSTRATE ANTIBIOTIC Acute Experiments 
Runs Type Concentration(mg COD/L) Type 
Concentration 
(mgSMX/L) 
Concentration
(mg COD/L) 
Run 1 Acetate  195 Control - - 
Run 2 Acetate  230 SMX 25 34.5 
Run 3 Acetate  250 SMX 50 69 
Run 4 Acetate  240 SMX 100  138 
Run 5 Acetate  217 SMX 200  276 
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Figure 3.3 : Chronic experiment reactor with SMX feeding. 
Table 3.4 : Outline of chronic experiments at a sludge age of 2 days. 
Runs Acclimation period 
Carbon 
Source 
Acetate 
Concentration
(mg COD/L) 
Antibiotic 
Concentration
(mg SMX/L) 
AntibioticCon
centration 
(mg COD/L) 
Run 1 0. day – control Acetate 195 - - 
Run 5 1. day Acetate + SMX 250 50 69 
Run 6 2. day Acetate + SMX 230 50 69 
Run 7 4. day Acetate 230 - - 
Run 8 6. day Acetate + SMX 230 50 69 
Run 9.1 8. day Acetate + SMX 230 50 72 
Run 9.2 8. day Acetate 230 - - 
Run 9.3 8. day SMX - 50 72 
Run 10.1 10. day Acetate + SMX 230 50 72 
Run 10.2 10. day SMX - 50 72 
Run 11.1 18. day Acetate + SMX 230 50 70 
Run 11.2 18. day Acetate 230 - - 
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3.3 Analytical procedures 
3.3.1 Standard methods 
Temperature of all experiments was maintained at 20 ± 1◦C. pH was kept around 7.0 
suitable for biological activity and minimum dissolved oxygen concentration of 2.0 
mg/L was supplied in the system, respectively. During the experiments an Orion 520 
pH meter was used for pH measurements and before each usage of the device the pH 
meter was calibrated. 
Samples, which were taken for soluble COD and antibiotic measurements, were 
filtered through 0.45 µm polyvinylidene fluoride (PVDF) syringe filters and COD 
samples were preserved with H2SO4. COD measurements were performed as 
described in the ISO 6060 method (ISO 6060, 1986). To understand the definite 
SMX concentration in terms of COD, macro COD measurements were also 
performed for stock antibiotic solution. The biomass concentration was monitored by 
total suspended solids (TSS) and volatile suspended solids (VSS) analysis as 
described in Standard Methods (APHA, 2005). TSS and VSS measurements were 
carried out after filtering the sample from Milipore AP40 glassfiber filters with an 
effective pore size of approximately 1.2 µm.  
The gas chromatographic method as described by Braunegg et al. (1978) for the 
determination of poly-β-hydroxybutyric acid (PHB) consists of a mild acid or 
alkaline methanolysis of poly-β-hydroxybutyric acid directly without previous 
extraction of PHB from the cells; this is followed by gas chromatography of the 3-
hydroxybutyric acid methylester. The method was characterized by high accuracy 
and excellent reproducibility, permitting determinations as low as 10-5 g/L. Only 4 h 
is required from sampling from the fermenter till completion of the PHB 
determination. 
The only pretreatment of cell samples is simply centrifugation, the time for which 
can be considerably shortened by the addition of methanol to the suspension; this is 
particularly so when the cells contain large amounts of PHB. After decanting the 
liquid phase, the cells can be directly subjected to the acidic methanol treatment prior 
to GC analysis. Centrifuged cells are suspended in a mixture of 2 mL methanol (3% 
H2SO4, v/v) and 2 mL chloroform, then heated at 100 °C for 4 hours. After cooling 
to room temperature, 1 mL H2O is added and the sample shaken vigorously for 10 
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min. The two phases are allowed to separate, during which cell detritus gathers at the 
interphase. The organic phase which is to be analyzed is placed in vials and can be 
stored unchanged at 4 °C for several weeks. Within the linear range of the detector 
used on the gas chromatograph (GC) apparatus, the results of this method for PHB 
determination depend neither on the volume of the cell suspension nor on the PHB 
content of the cells; the maximum standard deviation was ± 0.5% (Braunegg et al., 
1978). 
3.3.2 Antibiotic measurements 
SMX samples were measured by high-performance liquid chromatography (HPLC, 
Agilent 1100 Series, USA) equipped with a Diode-Array Detector (G1315A, Agilent 
Series) and Novapack reverse phase C18 column. Detector was adjusted at a 
wavelength of 280 nm. The SMX samples filtered through 0.45 µm Milipore 
membrane filters were transferred to HPLC vials. Methanol–water solution (30:70, 
v/v) was used as mobile phase at a flow rate of 1.1 mL/min as proposed by Beltran et 
al. (2008). Mobile phase was acidified with phosphoric acid (0.1 %) at pH 2.5. 
Injection volume was selected as 40 µL. A calibration curve was plotted for SMX 
measurements with Diode Array Detector at 280 nm (Figure 3.4). 
 
Figure 3.4 : SMX calibration curve forobtained for HPLC measurements. 
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4.  RESULTS AND DISCUSSION 
4.1 Acclimation Studies of Control Reactor 
A laboratory-scale fill and draw reactor, namely “control reactor” a net volume of 4 
L was operated at a sludge ageof 2 days with the initial carbon source concentration 
of approximately 400 mg COD/L. Acetate representing readily biodegradable 
substrate was chosen as sole carbon source. pH was kept in the range of 7.0 to 8.0, 
suitable for biological activity and the temperature was maintained at 20 ± 1˚C 
during the operation of reactor. At steady state conditions, biomass concentration of 
reactor was stabilized approximately 360 mg VSS/L, yielding the S0/X0 ratio of 1.1 
mg COD/mg VSS, respectively.  
In summary, the control reactor characteristics at steady state conditions were given 
in Table 4.1. The SS, VSS and VSS/SS ratio of the control reactor were monitored in 
a period of 5 months in detailed. Reactor monitoring data can be seen in Figure 4.1 
and Figure 4.2.The pH measurements and influent and effluent COD concentrations 
of the control reactor in a period of 5 months were also represented in Figure 4.3 and 
Figure 4.4. 
Table 4.1 : Steady state characteristics of the control reactor. 
Carbon 
Source 
SS VSS VSS/SS S0/X0 CODinf. CODeff. 
Removal 
efficiency 
mg 
SS/L 
mg 
VSS/L - 
mgCOD/
mgVSS mg/L mg/L % 
Acetate  505 360 0.71 1.1 400 45 89 
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Figure 4.1 : SS and VSS results of the control reactor. 
 
Figure 4.2 : VSS/SS ratio of the control reactor. 
 
Figure 4.3 : pH measurements of the control reactor. 
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Figure 4.4 : Influent and effluent soluble COD concentrations of the control reactor. 
4.2 Experimental Results 
4.2.1 Evaluation of control experiment 
First run of respirometric experiments was performed with using the acetate as sole 
carbon source and biomass taken from the control reactor in order to investigate the 
biomass behaviour under steady state conditions (Run 1). Respirometric test was 
started with the approximately same loading ratio (S0/X0) with control reactor. For 
this reason VSS and substrate concentrations were diluted by 1/2 ratio. After 
observation of the endogenous decay level in terms of straight line, the acetate was 
added to OUR reactor of respirometry as carbon source. 
The oxygen utilization rate (OUR) curve obtained from biodegradation of acetate 
was used as control for evaluating the acute and chronic effects of antibiotic on 
biomass (Figure 4.5). In other words, the impact was interpreted by changes inflicted 
by antibiotics on the shape of the initial OUR profile obtained in the control test 
conducted without antibiotic addition. The OUR, defined as the rate of oxygen 
utilization in biochemical processes in the activated sludge models, is the change 
observed in the dissolved oxygen concentration (SO) in time due to biochemical 
transformations. Thus, OUR is an overall process rate reflecting the cumulative 
impact of all oxygen/energy consuming reactions. The OUR curve obtained from the 
biodegradation of the acetate is shown in Figure 4.5. The maximum oxygen uptake 
rate of the biomass gave the first peak around 80 mg/L.h in 58 minutes, which is due 
to readily biodegradable COD component in the system. The area under the OUR 
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curve has shown that the total oxygen consumption for defined period of time (i.e. 
one minute).  
 
Figure 4.5 : OUR profile of the control experiment versus time (Run 1). 
The COD removal efficiency of acetate in Run 1 was given in the Figure 4.6 which 
indicates removal of all influent acetate in the control reactor during a period of time. 
The organic substrate (acetate) used in the experiments is by nature totally 
biodegradable; this is one of the main reasons for its selection and recommendation 
as the standard substrate for biodegradation experiments. Because the biodegradable 
COD in the control reactor was completely depleted after the OUR profile dropped to 
the initial endogenous respiration level. 
 
Figure 4.6 : Soluble COD profile of the control experiment versus time (Run 1). 
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4.2.2 Evaluation of acute experiments 
Acute experiments were conducted on the activated sludge to determine acute effects 
of SMX on the activated sludge and carbon source removal performance. Acute 
effects were characterized by sudden exposure to the substance and microbial system 
is exposed to the antibiotic for the first time. According to literature review, 
antibiotics remain nonbiodegradable for the short term tests as acute inhibition effect. 
Acute respirometric tests were also started with the approximately same loading ratio 
(S0/X0) with control reactor. After observation of the endogenous decay level in 
terms of straight line, the SMX was added to OUR reactor with carbon source. While 
approximately200 mg/L acetate was added to system at OUR experiments, the 
antibiotic was supplied in different concentration in order to evaluate the acute 
effects of SMX on the carbon source removal performance.  
As mentioned before, the OUR tests were conducted with four different antibiotic 
concentrations from 25 mg/L to 200 mg/L, mainly because they are representative of 
the range commonly encountered in the individual effluent streams at related 
pharmaceutical plants (Ozkok et al, 2011). The results are expected to be meaningful 
because removal at the source is always advocated as the best means of controlling 
these chemicals. All experiments with antibiotic were conducted in duplicate. The 
summary of control and acute experiments were shown in Table 4.2. 
Table 4.2 : Control and acute experiments at a sludge age of 2 days. 
SUBSTRATE ANTIBIOTIC Acute Experiments 
Runs Type Acetate Conc. (mg COD/L) Type 
SMX Conc. 
(mg SMX/L) 
SMX Conc. 
(mg COD/L) 
VSS 
(mg VSS/L) 
Run 1 Acetate 195 Control - - 240 
Run 2 Acetate 230 SMX 25 34.5 274 
Run 3 Acetate 250 SMX 50 69 239 
Run 4 Acetate 240 SMX 100 138 273 
Run 5 Acetate 217 SMX 200 276 246 
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Acute effect of 25 mg/L antibiotic addition to acetate acclimated biomass was 
investigated in Figure 4.7. Run 2 was started with an initial VSS concentration of 
274 mg/L. The OUR curve reaches a maximum level of 75 mg/L.h in 82 minutes.  
 
Figure 4.7 : OUR profile versus time (Run 2). 
Addition of different concentrations of antibiotic did not change the removal 
efficiency of acetate in the activated sludge system. In addition, SMX removal was 
not observed during a period of time with the different concentration of antibiotic 
addition. Figure 4.8 shows soluble COD profile and 25 mg SMX/L antibiotic 
measurement. Antibiotic was not removed with respect to time as shown in figure 
and the removal of acetate was also calculated by substracting the COD of SMX 
from total soluble COD.  
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  (b) 
      Figure 4.8 : Removal efficiencies of Run 2 (a) soluble COD and acetate profiles 
(b) SMX profiles. 
OUR profile of 50 mg/L SMX addition was displayed in Figure 4.9.Run 3 was 
started with an initial VSS concentration of 239 mg/L. The OUR curve reaches a 
maximum level of 66 mg/L.h in 87 minutes. Figure 4.10 also shows acute effect of 
50 mg/L SMX concentration and soluble COD profile.  
 
Figure 4.9 : OUR profile versus time (Run 3). 
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(a) 
 
(b) 
Figure 4.10 : Removal efficiencies of Run 3 (a) soluble COD and acetate profiles (b) 
SMX profiles. 
100 mg/L antibiotic addition to acetate acclimated biomass was determined in Figure 
4.11. Run 4 was started with an initial VSS concentration of 273 mg/L. The 
maximum oxygen uptake rate of the biomass gave the first peak around 62 mg/L.h in 
82 minutes. Figure 4.12 gives COD profile of 100 mg/L SMX concentration.  
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Figure 4.11 : OUR profile versus time (Run 4). 
 
  (a) 
 
(b) 
   Figure 4.12 : Removal efficiencies of Run 4 (a) soluble COD and acetate profiles   
(b) SMX profiles. 
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Finally, 200 mg/L SMX concentration was tested for acute inhibition effect to 
activated sludge system (Figure 4.13). Run 5 was started with an initial VSS 
concentration of 246 mg/L.The OUR curve reaches a maximum level of 53 mg/L.h 
in 100 minutes.  
 
Figure 4.13 : OUR profile versus time (Run 5). 
Figure 4.14 also displays acute effect of 200 mg/L SMX concentration and soluble 
COD profile. In summary, the COD profile results have indicated that antibiotic 
addition not to be effective for acetate removal in the activated sludge system as 
acute inhibition. 
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(b) 
Figure 4.14 : Removal efficiencies of Run 5 (a) soluble COD and acetate profiles   
(b) SMX profiles. 
The Figure 4.15 shows comparison of OUR profiles of control and acute experiments 
with respect to time. The antibiotic addition affected the shape of the OUR profile 
and the maximum OUR level. As it is seen from the Figure 4.15, addition of different 
SMX concentration to the activated sludge system decrease the maximum oxygen 
uptake rate of biomass in the acute tests. 
 
Figure 4.15 : Comparison of OUR profiles of all acute experiments with the control. 
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In control experiment, the OUR curve reaches a maximum level of 80 mg/L.h in 58 
minutes, then the curve decreases due to the consuming of readily biodegradable 
substrate as acetate. However, acute tests represent that acetate is consumed for a 
long period of time and also the maximum OUR peak level decreases slowly with 
increasing SMX concentration according to control experiment. In other words, 
SMX addition as acute impact only retard substrate utilization so that it would take 
more time to utilize the available substrate. 
4.2.3 Evaluation of chronic experiments 
Chronic effect is a response that is developed in time by constant exposure. Chronic 
tests to observe the long-term effects of antibiotic in the aerobic system. For 
understanding the chronic effect of SMX, a second fill and draw reactor was set up 
with the same conditions and fed by the antibiotic in addition to acetate. All 
experiments were done with the same antibiotic concentration as 50 mg SMX/L. This 
experimental observation of the study involved a period of 18 days after reaching 
steady state conditions. In this context, the SS, VSS and VSS/SS ratio of the 12 L 
chronic reactor were given in Figure 4.16. Effluent SMX concentrations were also 
monitored in a period of 18 days (Figure 4.17). If there is no antibiotic removal was 
assumed in chronic reactor, the antibiotic accumulation in system would be as given 
in Figure 4.17.  
 
Figure 4.16 : SS,VSS and VSS/SS ratio results of the 12 L chronic reactor. 
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Figure 4.17 : SMX effluent concentrations of the 12 L chronic reactor. 
10 runs of experiments were conducted; detailed information related to the batch 
experiments is given in Table 4.3. Experiments were conducted by using both acetate 
and antibiotic (called as mix), only acetate and only antibiotic as substrate under 
aerobic conditions. The chronic experiments were applied as; 
 on the second day of antibiotic feeding one experiment with mixed 
substrate 
 on the fourth day of antibiotic feeding one experiments with only acetate 
 on the sixth day of antibiotic feedingone experiment with mixed substrate 
 on the eighth day of antibiotic feeding three experiments with mixed 
substrate, only acetate and only SMX 
 on the tenth day of antibiotic feeding two experiments with mixed substrate 
and only SMX 
 on the eighteenth day of antibiotic feeding  two experiments with mixed 
substrate and only acetate 
In the all chronic experiments, the chronic reactor and the respiration vessel of 
respirometer wrapped in aluminum foil to prevent possible photodegradation of 
sulfamethoxazole. 
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Table 4.3 : Control and chronic experiments at a sludge age of 2 days. 
.
Runs Acclimation period 
Carbon 
Source 
Acetate 
Concentration 
(mg COD/L) 
Antibiotic 
Concentration 
(mg SMX/L) 
Antibiotic 
Concentration 
(mg COD/L) 
VSS 
(mg VSS/L) 
Run 1 0. day – control Acetate 195 Control - 240 
Run 5 1. day Acetate + SMX 250 50 69 239 
Run 6 2. day Acetate + SMX 230 50 69 144 
Run 7 4. day Acetate 230 - - 128 
Run 8 6. day Acetate + SMX 230 50 69 150 
Run 9.1 8. day Acetate + SMX 230 50 72 165 
Run 9.2 8. day Acetate 230 - - 165 
Run 9.3 8. day SMX - 50 72 165 
Run 10.1 10. day Acetate + SMX 230 50 72 110 
Run 10.2 10. day SMX - 50 72 110 
Run 11.1 18. day Acetate + SMX 230 50 70 120 
Run 11.2 18. day Acetate 230 - - 120 
 85 
Run 6 was conducted on the second day chronic impact of SMX to acclimated 
biomass. The OUR profile was given in Figure 4.18. The OUR curve reaches a 
maximum level of 75 mg/L.h in 60 minutes. The Figure 4.19 represents antibiotic 
measurements of 50 mg SMX/L and the trends of removal soluble COD in 2nd day 
chronic experiments (Run 6). The figure shows that 114 mg COD/L antibiotic 
concentration decreased to around 78 mg COD/L during time period. 
 
Figure 4.18 : OUR profile versus time (Run 6). 
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(b) 
Figure 4.19 : Removal efficiencies of Run 6 (a) soluble COD and acetate profiles   
(b) SMX profiles. 
Chronic effect of 50 mg SMX/L to activated sludge system was determined in 4th day 
as given in Figure 4.20. Run 7 shows that the respirometric evaluation of only acetate 
addition to system. The maximum oxygen uptake rate of the biomass gave the first 
peak around 32 mg/L.h in 122 minutes in Run 7. The Figure 4.21 shows antibiotic 
measurements and the removal efficiency of soluble COD in 4th day chronic 
experiments (Run 7).  
 
Figure 4.20 : OUR profiles versus time (Run 7). 
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 (a)  
 
(b) 
Figure 4.21 : Removal efficiencies of Run 7 (a) soluble COD and acetate profiles (b) 
SMX profiles. 
6th day chronic effect of 50 mg SMX/L was pointed in Figure 4.22 (Run 8). The 
OUR curve reaches a maximum level of 32 mg/L.h in 163 minutes. Soluble COD 
removal efficiencies and antibiotic measurements of 6th day were investigated in 
Figure 4.23 (Run 8). 40 mg COD/L antibiotic was removed with respect to time as 
shown in figure. 
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Figure 4.22 : OUR profile versus time (Run 8). 
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(b) 
     Figure 4.23 : Removal efficiencies of Run 8 (a) soluble COD and acetate profiles   
(b) SMX profiles. 
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8th day chronic effects of 50 mg SMX/L to system were shown in below Figure 4.24. 
In 8th day, three different OUR respirometric measurements were done at the same 
time. Run 9.1, Run 9.2 and Run 9.3 assigned respirometric determination of mixed 
substrate, only acetate addition and only SMX addition to the activated sludge 
system (Figure 4.24). The maximum oxygen uptake rate of the biomass gave the first 
peak around 42 mg/L.h in 124 minutes in Run 9.1 and 38 mg/L.h in 115 minutes in 
Run 9.2. In addition, as shown from Figure 4.24, the system progressed the 
endogenous decay level when only SMX added to the reactor (Run 9.3). 
 
Figure 4.24 : OUR profiles versus time (Run 9.1, Run 9.2 and Run 9.3). 
Soluble COD removal efficiencies and antibiotic measurements of 8th day of 50 mg 
SMX/L to chronic reactor were determined in Figure 4.25, Figure 4.26 and Figure 
4.27 (Run 9.1, Run 9.2 and Run 9.3), respectively.42 mg COD/L antibiotic was 
removed with respect to time as shown in figures. 
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(b) 
         Figure 4.25 : Removal efficiencies of Run 9.1 (a) soluble COD and acetate 
profiles (b) SMX profiles. 
 
(a) 
 
(b) 
         Figure 4.26 : Removal efficiencies of Run 9.2 (a) soluble COD and acetate 
profiles (b) SMX profiles. 
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 (a) 
 
(b) 
Figure 4.27 : Removal efficiencies of Run 9.3 (a) soluble COD and acetate profiles 
(b) SMX profiles. 
In the below Figure 4.28, it was observed that 10th day chronic effects were 
investigated (Run 10.1 and Run 10.2). OUR curve reaches a maximum level of 58 
mg/L.h in 193 minutes. Again, the system progressed the endogenous decay level 
when only SMX added to the reactor as shown from Figure 4.28(Run 10.2). The 
Figure 4.29 indicates measurements of 50 mg SMX/L and the removal efficiencies of 
total soluble COD and acetate in 10th day chronic experiments (Run 10.1). 44 mg 
COD/L antibiotic was removed with respect to time as shown in figure. 
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Figure 4.28 : OUR data versus time (Run 10.1 and Run 10.2). 
 
 (a) 
 
(b) 
          Figure 4.29 : Removal efficiencies of Run 10.1 (a) soluble COD and acetate 
profiles (b) SMX profiles. 
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Finally, 18th day chronic effects of 50 mg SMX/L to system were shown in Figure 
4.30. In 18th day, two different OUR respirometric measurements were done at the 
same time. Run 11.1 and Run 11.2 show investigation of mixed substrateand only 
acetate addition to the activated sludge, respectively (Figure 4.30). OUR curve 
reaches a maximum level of 35 mg/L.h in 177 minutes in Run 11.1 and 25 mg/L.h in 
169 minutes in Run 11.2.  
 
Figure 4.30 : OUR data versus time (Run 11 and Run 11.1). 
Antibiotic measurement of 18th day of 50 mg SMX/L on chronic reactor of 12 L 
were not measured in HPLC. 18th day chronic experiment included only COD 
removal efficiencies of SMX 50 and acetate mixture and only acetate in Figure 4.31. 
 
Figure 4.31 : COD removal efficiencies of  Run 11.1 and Run 11.2. 
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Comparison of the OUR profiles of all chronic experiments (with mixed substrate, 
with only acetate and with only antibiotic) were indicated in Figure 4.32, Figure 4.33 
and Figure 4.34, respectively. 
 
         Figure 4.32 : Comparison of the OUR profiles of all chronic experiments      
(with mixed substrate). 
 
          Figure 4.33 : Comparison of the OUR profiles of all chronic experiments        
(with mixed substrate). 
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       Figure 4.34 : Comparison of the OUR profiles of all chronic experiments (with 
mixed substrate). 
4.3 Modeling of Experimental Results 
Modeling is now regarded as a useful instrument for understanding and interpreting 
biodegradation and related mechanisms of substrate utilization. Recent models 
structured for this purpose operate with two major conceptual developments: (i) they 
use chemical oxygen demand (COD) and the organic carbon parameter and include 
COD fractions with different biodegradation characteristics based on the pioneering 
works of Dold et al. (1980) and Ekama et al. (1986); (ii) they incorporate dissolved 
oxygen concentration (S0) as a significant model component which allow to calibrate 
and evaluate oxygen uptake rate profiles (Cokgor et al, 2011). 
4.3.1 Modeling of control and acute experiments 
Modeling consisted of analyzing and calibrating the OUR and PHA profiles. In this 
context, a mechanistic model involving model components and 
kinetic&stoichiometric parameters was developed for both acetate and SMX. 
Modified ASM3 model was used in this study. The model structure were composed 
of four model components, namely the readily biodegradable COD, SS; active 
heterotrophic biomass, XH; storage products, XSTO and dissolved oxygen, SO. 
Generation of residual products (XP) as a decay associated processes is implicitly 
involved in the model by means of the coefficient fP which acts as a correcting factor 
for oxygen consumption due to endogenous respiration. The model structure 
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involved four microbial processes: growth on SS; storage and growth on stored PHA 
and decay of XH by means of endogenous respiration (Orhon et al, 2009b).The 
growth process associated with XH was defined as conventionally adopted Monod-
type equations. Both endogenous decay mechanisms were described as first-degree 
reactions with respect to biomass concentrations. The storage process was defined in 
terms of a similar Monod-type of an expression where kSTO denotes the maximum 
storage rate (Karahan et al, 2006). The matrix representation of modified ASM3 
structure was indicated in Table 4.4. 
  Table 4.4 : Matrix representation of modified ASM3 model structure in control and 
acute experiments. 
Component 
SO2 SS XH XSTO XP Process rateProcess 
Storage of PHA  STOY 1  -1  YSTO  . .SSTO H
S S
Sk X
K S  
Growth of XH 
1 H
H
Y
Y
  1
HY
  1   . .SH H
S S
S X
K S
   
Growth on PHA 
1 H
H
Y
Y
   1 1
HY
   .STO STOX  
Decay of XH -(1-fp)  -1  fp .H Hb X
Kinetic and stoichiometric parameters of the modified ASM3 model were estimated 
using the AQUASIM simulation program(Reichert et al, 1998). In addition, 
modeling study was also performed for parameter estimation. The parameter 
estimation study provided a basis for observing the change in the kinetic parameters 
of activated sludge while adopting to different conditions (Insel et al, 2012). 
Model simulation results of OUR profile and PHA data of control experiment (Run1) 
were shown in Figure 4.35 and Figure 4.36, respectively. According to simulation 
results, the model was calibrated with a maximum specific growth rate, µHmax of 
8.5/day for the portion of the biomass. The initial XH concentration was determined 
as 300 mg cell COD/L. The calibration of the initial endogenous respiration part of 
the OUR curve also yielded an endogenous decay coefficient, bH of 0.24/day. The 
model calibration was performed with the assumption of a yield coefficient YH of 
0.66 mg cell COD/mg COD and a storage yield coefficient YSTO of 0.80 mg cell 
COD/mg COD (Yavaşbay, 2010). The coefficient for residual products generation, fP 
was taken as 0.20 in the all experimental runs (Orhon et al, 2009b). 
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Figure 4.35: Model simulation of OUR profile for Run 1. 
 
Figure 4.36: Model simulation of PHB data for Run 1. 
Simulation results showed that the half-saturation constant (KS) was found as 15mg 
COD/L with 2 days of sludge age. In the other study about the similar research, this 
value was found 6 mg COD/L with the same operational conditions only difference 
in 10 days of sludge age (Ural, 2012). Another study also showed that reducing the 
sludge age (SRT) from 10 to 2 days elevated the half-saturation constant for growth 
(KS) from 5 to 25 mg COD/L (Insel et al, 2012). 
Modeling results reflected the PHA storage, yielding with a kSTO value of 5.9/day. 
The maximum storage rate was nearly same as the default value of ASM3. For all 
experimental runs, the half saturation constant for storage KSTO was obtained as 0.3 
mg COD/L (Ural, 2012). 
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The additional batch experiments were carried out to provide a model evaluation for 
acute inhibition effects of SMX on the biodegradation of acetate. Model simulation 
was applied to SMX-25,SMX-50and SMX-100 acute experimental results. Model 
simulation results of OUR profile and PHB data for Run 2 was shown in Figure 4.37 
and Figure 4.38, respectively. According to the Run 2 (SMX-25), half saturation 
constant (KS) was found 33 mg COD/L, whereas it was 15 mg COD/L for the control 
experiment. In the Run 2, endogenous decay rate (bH) increased from 0.24/day to 
0.35/day and maximum heterotrophic growth rate (μHmax) decreased from 8.5/day to 
8/day. In addition, maximum specific growth rate on the stored products (μSTO), the 
maximum storage rate (kSTO) and half saturation constant for storage (KSTO) were 
found the control experiment. 
 
Figure 4.37 : Model simulation of OUR profile for Run 2. 
 
Figure 4.38 : Model simulation of PHB data for Run 2. 
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Model simulation results of OUR profile and PHB data for Run 3 (SMX-50) were 
indicated in Figure 4.39 and Figure 4.40, respectively. Run 3 (SMX-50) modelling 
results of modified ASM3 indicated that maximum heterotrophic growth rate (μHmax), 
half saturation constant for readily biodegradable substrate (KS), endogenous decay 
rate (bH), maximum specific growth rate on the stored products (μSTO),the maximum 
storage rate (kSTO) and half saturation constant for storage (KSTO) were the same as 
the Run 2. 
 
Figure 4.39 : Model simulation of OUR profile for Run 3. 
 
Figure 4.40 : Model simulation of PHB data for Run 3. 
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Model simulation results of OUR profile and PHB data for Run 4 were illustrated in 
Figure 4.41 and Figure 4.42 respectively. In the Run 4 (SMX-100), maximum 
heterotrophic growth rate (μHmax) decreased from 8/day to 6/day whereas half 
saturation constant (KS) was the same value with the Run 3. As it can be seen other 
parameters in the Run 4, the maximum specific growth rate for storage (µSTO) also 
decreased according to other acute experiments. The model simulation results based 
on modified ASM3 of Run 1, Run 2, Run 3 and Run 4 were given in Table 4.5 in 
details. 
 
Figure 4.41 : Model simulation of OUR profile for Run 4. 
 
Figure 4.42 : Model simulation of PHB data for Run 4. 
 
0
10
20
30
40
50
60
70
0 0.05 0.1 0.15 0.2 0.25 0.3
O
U
R
 (m
g 
O
2/l
.h
)
Time (day)
OUR_model_total OUR_data_SMX_100
0
10
20
30
40
50
60
70
0 0.05 0.1 0.15 0.2 0.25 0.3 0.35
PH
B
 (m
g 
C
O
D
/L
)
Time (day)
PHB_model_total PHB_data_SMX_100
 101 
Table 4.5 : Calibration results of the control and acute experiments. 
Assumptions: YH = 0.66 g COD/g COD and YSTO = 0.80 g COD/g COD (Yavaşbay, 2010). 
Evaluated of the maximum specific growth rate(µHmax) and the half saturation 
coefficient (KS) in the acute experiments, μHmax decreased from 8.5/day to 6/day 
while KS increased from 15 mg COD/L to 33 mg COD/L. As related to this subject, 
Novak et al. (1994) argued that batch reactors would favor the fast growers group in 
the biomass and generate a higher µHmax value for the same substrate with respect to 
biomass growing in continuous systems. According to Grady et al. (1996), the 
maximum specific growth rate (µHmax), is closely related to the r-RNA level of the 
cell as it controls the protein synthesis mechanism. Then, culture history (sludge age, 
dilution rate, etc.) which regulates the biochemical mechanisms within the cell is 
likely to affect the growth kinetics (Orhon et al, 2009b). Furthermore, a recent study 
has shown that substrate utilization was highly influenced by the r-RNA level and the 
activity of substrate transforming enzymes (Lavallée et al, 2005). The latter basically 
reflects substrate affinity of microorganisms. This affinity increases with higher 
activity of transport enzymes inducing lower values for the half saturation 
coefficient(KS) (Daigger and Grady, 1982; Ferenci, 1999). As further support to this 
situation, Kovarova-Kovar and Egli (1998) stated that the microbial cells could 
adjust their properties within a window of μH-KS plane depending upon the type of 
Model 
Parameters Unit 
Control 
(Run 1) 
Acute 
SMX-25 
(Run 2) 
Acute 
SMX-
50(Run 3) 
Acute 
SMX-100       
( Run 4) 
μHmax 1/day 8.5 8 8 6 
KS mg COD/L 15 33 33 33 
bH 1/day 0.24 0.35 0.35 0.35 
kSTO 1/day 5.9 5.9 5.9 5.9 
μSTO   1/day 3 3 3 2.1 
KSTO   mg COD/L 0.3 0.3 0.3 0.3 
fES - 0.05 0.05 0.05 0.05 
fEX - 0.15 0.15 0.15 0.15 
State 
variables 
Unit 
 
Total 
biomass 
mg VSS/L 240 274 239 273 
XH mg COD/L 300 280 265 310 
Activity  % 88 72 78 80 
SACini. mg COD/L 195 230 250 240 
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the bacteria having oligitrophic and copiotrophic properties. The oligitrophic 
properties correspond to lower maximum μH-Ks domain, however, the copiotrophic 
properties indicates higher μH-KS levels. For instance, microorganisms are able to 
increase their affinity (<<KS) during long-term adaptation from high to low 
substance concentration in such way that glucose is transported via high affinity 
galactose binding protein/maltose system rather than the glucose phosphotransferase 
system (Yavaşbay, 2010). 
The model simulation results also showed that the OUR segments governing the 
direct growth and storage processes reveal that the biomass prefers to channel 
substrate (acetate) more to direct growth process rather than producing internal 
storage material (PHB) (Insel et al, 2012). Because, the maximum specific growth 
rate for storage (μSTO) decreased from 3/d to 2.1/d. 
4.3.2 Modeling of chronic experiments 
In chronic experiments, the model structure were composed of five model 
components and hydrolysis process added to the system so microorganisms 
consumed SMX as readily hydrolysable COD with a specific hydrolysis rate. The 
slowly biodegradable COD fraction was composed of SAC and SMX. Modified 
ASM3 model was used and the matrix representation of modified ASM3 structure 
was indicated in Table 4.6. 
In the chronic experiments, only the 1st day mix (Run 2); 6th day mix (Run 8), 8th day 
mix (Run 9.1), and 18th day mix (Run 11.1) were simulated by the modified ASM3 
model. Model simulation results of Run 2 were represented in Figure 4.39 and Figure 
4.40, respectively. Model simulation result of 6th day mix (Run 8) was shown in 
Figure 4.43. According to model simulation results, the maximum specific growth 
rate (µH) decreased from 8.5/day to 8/day in the 6th day chronic experiment due to 
constant addition of antibiotics to the system. Therefore, only a portion of acetate 
(167 mg/L) was utilized by the microorganisms in the growth process. The other 
portion of acetate (63 mg/L) made a complex with antibiotic (40 mg/L) that was 
consumed as readily hydrolysable COD fraction in the hydrolysis process. As from 
6th day chronic experiment, processes of storage and growth on stored PHA were 
disappeared. As a result of that, the metabolism of the activated sludge was shifting 
from storage to growth (Yavaşbay, 2010).  
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Table 4.6 : Matrix representation of modified ASM3 model structure in chronic experiments. 
 
  
 
 
Component 
SO2 SS (SS+SMX)complex XH XSTO XP Process rate
Process 
Hydrolysis of 
(SS+SMX)complex 
 1 -1    
 
  S complexS complex
S SMX /
. .
S SMX /
H
h H
X H
X
k X
K X

 
 
Storage of PHA  STOY 1  -1   YSTO  . .SSTO H
S S
Sk X
K S  
Growth of XH 
1 H
H
Y
Y
  1
HY
   1   . .SH H
S S
S X
K S
   
Growth on PHA 
1 H
H
Y
Y
    1 1
HY
   .STO STOX  
Decay of XH -(1-fp)   -1  fp .H Hb X
 
 104 
 
Figure 4.43 : Model simulation of OUR profile for Run 8. 
Model simulation result of Run 9.1 was illustrated in Figure 4.44. In the 8th day 
chronic experiment, the maximum specific growth rate (µHmax) again increased from 
8/day to 8.5/day. 175 mg/L acetate was utilized by the microorganisms in the growth 
process.  55 mg/L acetate made a complex with 42 mg/L antibiotic in the hydrolysis 
process. 
Figure 4.44 : Model simulation of OUR profile for Run 9.1. 
Model simulation result of 18th day mix (Run 11.1) was shown in Figure 4.45. These 
model parameter results were found the with same 8th day experiment. 200 mg/L 
acetate was utilized by the microorganisms in the growth process.30 mg/L acetate 
made a complex with 44 mg/L antibiotic in the hydrolysis process. 
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Figure 4.45 : Model simulation of OUR profile for Run 11.1. 
According to modeling of chronic experiments, the biomass is able to increase its 
primary growth metabolism and minimize storage capability. Because, the storage 
process disappeared with the acclimation of activated sludge to SMX. For this 
reason, μSTO, kSTO, KSTO and YSTO were not estimated in chronic experiments. The 
model simulation results based on modified ASM3 of Run 1, Run 8, Run 9.1 and 
Run 11.1 were given in Table 4.7 in details. 
Table 4.7 : Calibration results of the chronic experiments. 
Assumptions: YH = 0.66 g COD/g COD (Yavaşbay, 2010). 
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Model 
Parameters Unit 
Control 
(Run 1) 
1st day 
(Run 3) 
6th day 
(Run 8) 
8th day 
(Run 9.1) 
18th day 
(Run 11.1)
μHmax 1/day 8.5 8 8 8.5 8 
KS mg COD/L 15 33 33 15 15 
bH 1/day 0.24 0.35 0.35 0.35 0.35 
kSTO 1/day 5.9 5.9 - - - 
μSTO   1/day 3 3 - - - 
KSTO   mg COD/L 0.3 0.3 - - - 
kh 1/day - - 2.4 2.4 2.4 
KX 
mg COD/ 
mg COD 
- - 0.15 0.15 0.15 
fES - 0.05 0.05 0.05 0.05 0.05 
fEX - 0.15 0.15 0.15 0.15 0.15 
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Table 4.8 : Calibration results of the chronic experiments (cont.). 
 
 
 
 
 
 
 
 
 
 
 
 
State 
variables Unit 
Control 
(Run 1) 
1st day 
(Run 3) 
6th day 
(Run 8) 
8th day 
(Run 9.1) 
18th day 
(Run 11.1)
Total 
biomass 
mg VSS/L 182 239 141 165 120 
XH mg COD/L 300 265 170 200 140 
Activity  % 88 72 85 85 82 
SACini. mg COD/L 195 250 230 230 230 
SMXini. mg COD/L - 69 69 69 69 
SACuti. mg COD/L 215 255 167 175 200 
(SAC+SMX)comp. mg COD/L - 12 63+40 55+42 30+44 
 107 
5.  CONCLUSION 
The objective of this study was to investigate acute and chronic inhibition effects of 
antibiotics on the biodegradation of acetate. Therefore, this research focused on the 
fate and effect of sulfamethoxazole (SMX)which represents sulfonamide group of 
antibiotics. The inhibitory impact of SMX on the biodegradation of acetate by an 
acclimated microbial culture was investigated under aerobic conditions at a sludge 
age of 2 d.  
Respirometric tests were performed for the assessment of substrate biodegradation 
behaviour with addition of SMX. The acclimated biomass was used for respirometric 
experiments which displayed a significant information about the inhibitory impact of 
SMX. To evaluate the acute effects of SMX on the acetate removal performance, the 
antibiotic was given to system with different pulse feedings of 25 mg/L, 50 mg/L, 
100 mg/L and 200 mg/L of SMX concentrations. Antibiotic removal was not 
observed with the different concentration of antibiotic addition during a period of 
time in the acute experiments. 
According to model simulations results of acute experiments, maximum specific 
growth rate (µHmax) decreased from 8.5/day to 6/day whereas the half saturation 
coefficient (KS) increased from 15 mg COD/L to 33 mg COD/L with the addition of 
SMX to the system. In addition, the maximum specific growth rate for storage (μSTO) 
decreased from 3/d to 2.1/d. The results indicated that the metabolism of the 
activated sludge was shifting from storage to growth. The biomass prefers to channel 
substrate (acetate) more to direct growth process rather than producing internal 
storage material (PHB).  
Additional respirometric experiments were conducted on the activated sludge to 
determine chronic inhibition effects of SMX. In the chronic experiments were done 
with continuous feeding of 50 mg/L of SMX concentration. According to model 
simulations results, a portion of acetate was utilized by the microorganisms in the 
growth process. The other portion of acetate made a complex with antibiotic that was 
consumed as readily hydrolysable COD fraction in the hydrolysis process. 
 108 
Approximately 40 mg COD/L antibiotic was removed throughout the chronic 
experiments with a specific hydrolysis rate. Moreover, the biomass is able to increase 
its primary growth metabolism and minimize storage capability. Because, the storage 
process disappeared with the acclimation of activated sludge to SMX in the chronic 
experiments. 
As a consequence, all acute and chronic results under aerobic conditions at a sludge 
age of 2 d demonstrated that the metabolism of the activated sludge was shifting 
from storage to growth. The biomass prefers to direct growth process rather than 
storage process. 
Finally, it is recommended that future studies on antibiotics should include 
biodegradation of antibiotics and their toxic/inhibition effects on microbial 
community which must be defined in these systems. Because, there are studies present 
in the literature considering the detection and the biodegradation of these substances 
under different environmental conditions has been tried to determine by only 
conventional methods. Studies on the microbial groups and species that are responsible 
for degradation have not been done yet. 
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